
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145923210.1021/acsomega.8b01378ArticleThree-Component One-Pot Approach to Highly Efficient
and Sustainable Synthesis of the Functionalized Quinolones via Linear/Branched
Domino Protocols, Key Synthetic Methods for the Floxacin of Quinolone
Drugs Bai Hairui †‡Liu Fujun †Wang Xiaojing †Wang Ping †Huang Chao *†‡†School
of Chemistry and Environment and ‡Engineering Research Center of
Biopolymer Functional Materials of Yunnan, Yunnan Minzu University, Yuehua Street, Kunming 650500, P. R. China* E-mail: huangchao@ynu.edu.cn (C.H.).14 09 2018 30 09 2018 3 9 11233 11251 19 06 2018 20 08 2018 Copyright © 2018 American Chemical
Society2018American Chemical
SocietyThis is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License, which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.

The development of a clear chemical
process to produce diverse
value-added chemicals from low-cost raw materials is a particularly
attractive concept and represents a considerable challenge in sustainable
organic synthesis. Herein, two highly efficient and clear methods
for the synthesis of quinolone derivatives based on a linear/branched
domino protocol under sustainable conditions were established. The
main advantages of these protocols are the simple experimental procedure,
high bond-forming efficiency, inexpensive readily available starting
materials, moderate to excellent yields with good functional group
compatibility, and nonchromatographic purification, which render these
methods particularly attractive for the sustainable preparation of
biologically and medicinally interesting molecules. To demonstrate
the practical utility of our protocol, existing pharmaceutical sarafloxacin
was successfully synthesized. Furthermore, a postulated reaction pathway
including condensation reaction/nucleophilic aromatic substitution/Friedel–Crafts
reaction for these domino reactions is also discussed.

document-id-old-9ao8b01378document-id-new-14ao-2018-01378sccc-price
==== Body
Introduction
The U. S. Environmental
Protection Agency (EPA) defined the “green
chemistry” concept as “the design of chemical products
and processes that reduce or eliminate the use or generation of hazardous
substances”.1,2 In the green chemistry or sustainable
chemistry field, the ideal synthesis should be a combination of a
number of environmental, health, safety, and economic factors.3 By adopting all of these concepts in the laboratory,
chemists can design more efficient and environmentally friendly reactions.
Toward fulfilling these goals, multicomponent domino reactions can
be recognized as one of the most direct, effective, and rapid methods
for greener organic synthesis. Typical domino reactions proceed in
linear/branched mode;4 (a) linear domino
protocol: two or more coupled reactions linked together are carried
out in one pot. In the first stage, the reaction materials give rise
to a reactive intermediate which then reacts with a third component
and so on until the sequence is terminated; (b) branched domino protocol:
multicomponent materials simultaneously undergo parallel reactions
in a single reaction vessel, with multiple chemical bond formation.
Intermediates will be generated in processes under identical conditions,
which can involve in the next step as reactants to form the product.
These protocols can be used for a multiplication effect5 to precisely splice complicated architectures
from simple, accessible materials atom-economically,6 and they take the advantages of avoiding time-consuming
protection/deprotection steps7 and isolation
of intermediates.8 Domino reactions are
also recognized to have minimal waste generation and therefore can
be categorized as sustainable chemical transformations.9

Nitrogen-containing heterocyclic functionalities
append notable
physical and bioactivity properties to organic molecules.10 Amongst the numerous heterocyclic compounds,
quinolones are regarded as privileged scaffolds and are found in many
biologically active natural products and synthetic drugs.11 Quinolone derivatives can be used in various
therapeutic areas because of their antitumor, antimalarial, antiviral,
anti-HIV, anti-inflammatory, antimicrobial activities, and so forth.12 To date, numerous quinolone drugs (QNSs) are
widely utilized in clinical practice such as sarafloxacin,13 ciprofloxacin,14 antofloxacin,15 pazufloxacin,16 prulifloxacin,17 delafloxacin,18 elvitegravir,19 (Figure 1) and so forth. Nevertheless, it is true that the increased
demand and shortage of QNS alternatives have made the prices of QNSs
remain high, such as delafloxacin or elvitegravir. Consequently, these
reasons have fascinated medicinal chemists worldwide, who are continually
seeking to develop new synthetic protocols for building functional
and diverse quinolones for future drug development.

Figure 1 Representative examples
of QNSs.

To develop effective processes
for assembling the quinolone ring
system, numerous synthetic methods for quinolone preparation by decarboxylation
cyclization (e.g. Camps,20 Conrad–Limpach,21 Gould–Jacobs cyclizations,22 etc.) and the transition-metal-catalyzed cyclizations23 which can be classified as either cross-coupling
reactions of activated aryl rings or coupling reactions based on arene
C–H activation (e.g. palladium-catalyzed carbonylation, titanium-mediated
reductive coupling, ruthenium-catalyzed reduction reactions, etc.)
have been extensively investigated. In 2013, Long’s group developed
a K2CO3-catalyzed route for the synthesis of
substituted 4-quinolones from 3-oxo-3-arylpropanoates and amides.24 In 2015, Peng’s group presented a Pd-catalyzed
synthetic methodology for the formation of quinolones.25 In our previous paper, we developed a new type
of one-pot cascade with a convenient and rapid synthetic procedure;
a series of highly substituted quinolones were synthesized.26 To date, although various approaches to the
preparation of quinolone derivatives have been developed, an alternative
strategy to generate the quinolone derivatives from low-cost raw materials
via an environmentally benign and sustainable procedure is still in
great demand.

In this work, we designed two types of domino
model reactions and
employed triethyl orthoformate as a C1 building block and
inexpensive readily available starting materials, dicarbonyl compounds
and aniline derivatives, via clear chemical processes to synthesize
two types of quinolone derivatives under sustainable conditions. Synthesis
of quinolones A: it is expected that a sequential condensation
reaction (C=C bond formation) and nucleophilic aromatic substitution
(C–N bond formation) would yield the intermediate enamino diester
which would undergo a Friedel–Crafts reaction to afford the
quinolones, and only ethanol was produced as a byproduct. Synthesis
of quinolones B under solvent- and catalyst-free conditions:
the materials in the reactor were simultaneously subjected to one
condensation reaction (C=C bond formation) and two nucleophilic
aromatic substitutions (C–N bond formation) to yield a different
type of quinolone. In these two domino synthetic processes, the molecules
in the reaction system overcome the adverse effects of entropy, fragment
preface automatic connection, and conversion to the new structure
effectively to construct a complicated chemical structure. This synthetic
method is an attractive process for the preparation of chemical structures
in a sustainable manner (Scheme 1).

Scheme 1 Pathways for the Synthesis of Quinolones Based on
the Domino Strategy
Results and Discussion
Efficient and elegant synthesis
would be an ideal testing ground
to demonstrate the power and potential of this domino strategy. We
commenced our synthesis using benzoylacetic acid ethyl ester, triethyl
orthoformate, and aniline as test substrates to verify the linear
domino protocol. Initially, EtOH was used as a solvent in the whole
domino processes, and Eaton’s reagent27 was used as a cyclization reagent; in domino process 2, the conversion
(26%) was very poor (Table 1, entry 1), and we were pleased to obtain the formation of
a small amount of the product 1a. Further screening of
the reaction temperatures and solvents showed that conducting the
reaction under solvent-free conditions at 130 °C (Domino process
1) gave a better result (entries 2–8, entry 8). Only a trace
amount of the product was observed when the reaction was carried out
in other solvents such as AcOH or Ac2O (entries 2 and 3).
With the chosen system of reactants using AcOH as the solvent, we
could not prevent Schiff base formation with the amine, even though
only 1.0 equiv of the amine was used. Thus, reaction conditions with
an increased temperature of 130 °C and with solvent-free conditions
were selected for further investigation (entry 8). Subsequently, various
cyclization reagents were investigated. Among them, PPA (polyphosphoric
acid)26 and diphenyl ether were also efficient
catalysts for this transformation (entries 10 and 12), whereas H2SO4 failed to give the product (entry 13). To our
delight, the reaction time could be reduced to 0.75 h when diphenyl
ether was employed as the cyclization reagent (entry 10). The yield
decreased significantly when the reaction was conducted at lower (110
°C) or higher temperatures (140 °C) (entries 9 and 11).
The reaction failed to give the product in the absence of the cyclization
reagent (Domino process 2) and only the intermediate enamino diester
was generated (entry 17). To improve the efficiency, the reactions
were performed under microwave irradiation. The results showed that
the mixture of PPA with raw materials self-ignited during the heating
process, and using Eaton’s reagent or diphenyl ether as a cyclization
reagent could not give the target product (entries 14–16).
Finally, taking into account diphenyl ether that can be distilled
to recover and the transformation efficiency that conforms to the
pivotal role of sustainability, we chose diphenyl ether as the cyclization
reagent. Accordingly, the optimized reaction conditions were as follows.
Domino process 1, dicarbonyl compound (2.0 mmol), triethyl orthoformate
(2.25 mmol), and aniline derivatives (2.0 mmol) without the catalyst
and solvent at 130 °C reacted for 24 h; Domino process 2, with
diphenyl ether reflux reacted for 0.75 h (Table 1, entry 10).

Table 1 Screening
Optimum Reaction Conditions
for the Model Reactiona,b
entry	solvent	cyclization
reagent	temp (1, 2) °C	time (1, 2) h	yield %c	
1	EtOH	Eaton’s
reagent	reflux, 100	24, 4.5	26	
2	AcOH	Eaton’s
reagent	reflux, 100	24, 4.5	—	
3	Ac2O	Eaton’s reagent	reflux, 100	24, 4.5	trace	
4	DMF	Eaton’s
reagent	reflux, 100	24, 4.5	50	
5	CH3CN	Eaton’s reagent	reflux, 100	24,
4.5	32	
6	dioxane	Eaton’s reagent	reflux, 100	24, 4.5	44	
7	toluene	Eaton’s
reagent	reflux, 100	24, 4.5	20	
8	—	Eaton’s
reagent	130, 100	24, 4.5	70	
9	—	Ph2O	110, reflux	24, 0.75	62	
10	—	Ph2O	130, reflux	24, 0.75	86	
11	—	Ph2O	140, reflux	24, 0.75	70	
12	—	PPA	130, 110	24, 9	67	
13	—	H2SO4	130, 90	24, 2	N.R	
14d	—	Eaton’s reagent	130, 70	24, —	—	
15d	—	Ph2O	130, 140	24, 0.75	trace	
16d	—	PPA	130, 70	24, —	self-ignite	
17	—	—	130, —	24, —	intermediate	
a Reaction conditions,
unless stated
otherwise: benzoylacetic acid ethyl ester (2.0 mmol), triethyl orthoformate
(2.25 mmol), and aniline (2.0 mmol) in one-pot; cyclization reagent:
Eaton’s reagent (0.2 mL), Ph2O (1.0 mL), PPA (0.2
g), and H2SO4 (0.2 mL).

b Temp (1, 2) °C and time (1,
2) h are the temperatures and time of the domino process 1 and domino
process 2, respectively.

c Values are the overall yields of
isolated products, determined by 1H NMR and 13C NMR spectroscopy.

d Reaction
was carried out using a
CEM Discover SP-Microwave synthesizer.

With the optimal reaction conditions in hand, we set
out to explore
the substrate generality of this transformation. The results are summarized
in Table 2. Anilines
with electron-withdrawing or electron-donating groups such as halogen,
nitro, trifluoromethyl, methyl, and methoxy at the para position reacted
smoothly with triethyl orthoformate and dicarbonyl compound powder
to give the corresponding products in good yields (Table 21b–1m, 2b–2k, 3b–3l, and 4b–4k). Among them, even trifluoromethyl or tert-butyl
groups on the aromatic ring could result in moderate yields (78% of 1g and 73% of 1l); the nitro-substituted aniline
gave the best yield (82% of 1f). Owing to the importance
of halogen groups in structure–activity relationship investigations
of QNSs, we also examined the reactivity of the halogen substituent
on the aryl ring involved in this reaction. Among these four halogens,
fluoro was the most suitable and the chloro was the second, but bromo
and iodo only gave the corresponding products in much lower yields
(74% of 1b, 71% of 1c, 67% of 1d, and 66% of 1e). When a bromo group was located at
the meta position, 1r (64% yield) was obtained. When
a methyl or methoxyl group was located at the same position, a single
product 1s was obtained in 58% yield and product 1t was obtained in 67% yield. The position of the substituent
significantly affected the reaction yield, and only 62% yield was
obtained when a methoxyl group was located at the ortho position of
aniline. Better yields could be achieved when multimethyl- and multihalogen-substituted
anilines were used (84% of 1u, 77% of 1v). 4-Benzylaniline and 4-chloro-4′-aminodiphenyl ether were
well tolerated under the optimized reaction conditions to give the
corresponding products 1w and 1x in good
yields. By analysis of the experimental results, either the electron-withdrawing
group or the electron-donating group could be located at any position
of the aniline; an electron-donating group substituted on the aromatic
ring disfavored the transformation with a marked decrease in the yield,
but an electron-withdrawing group substituted on the aromatic ring
showed the opposite effect which increased the electronic effect on
the yields of the reaction process 1 and 2. These results indicated
that the electronic effect of the substituent plays an important role
in the last nucleophilic aromatic substitution step (C–N bond
formation) of domino process 1.

Table 2 Substrate Scope of
the Reaction for
Quinolones Aa,b
a Reaction conditions, unless stated
otherwise: Domino process 1, 1 (2.0 mmol), 2 (2.25 mmol), and 3 (2.0 mmol) without the catalyst
and solvent at 130 °C reacted for 24 h; Domino process 2 with
diphenyl ether reflux reacted for 0.75 h.

b Isolated yield based on arylamine 3, nonchromatographic
purification.

To expand
the scope of the present approach, the scope of the dicarbonyl
compounds was also evaluated. The reactions of dicarbonyl compounds
substituted with phenyl, tert-butyl, and cyclopropyl
were carried out under the optimal reaction conditions and gave the
desired generated products (Table 22a–2p and 3a–3s) in moderate to excellent yields. Finally, diethyl malonate was
also used in the reaction and afforded the ethyl ester products (Table 24a–4p) in a slightly decreased yield (41–76%). The fact that diethyl
malonate is significantly more volatile than other esters may contribute
to the high stoichiometry required for its reactions.

To further
examine the scope and limitations of the reaction, we
tested other aromatic amines in the reaction (Table 2). The reaction selectively occurred at the
ortho position of the amine group when 1-aminonaphthalene was used
as the substrate; the desired products (1y, 2s, 3w, and 4r) were obtained in 63–73%
yield. Besides, quinolin-6-amine (1za) and 3-aminoquinoline
(1zb) could also be used as substrates in this reaction.

To verify the structure of the quinolone derivatives, 2a was selected as a representative compound and characterized by X-ray
crystallography (CCDC 1580410, ref (28), Figure 2).

Figure 2 Single-crystal X-ray structure of 3-pivaloylquinolin-4(1H)-one.

Growing awareness of
environmental concerns has led to the increase
need for more environmentally acceptable processes in the organic
synthesis chemical industry. Having established a robust linear domino
synthesis of a diverse array of quinolones, we turned our attention
to investigate whether the approach could be extended to perform multiple
simultaneous reactions in a single vessel to atom- and step-economically
synthesize quinolones. In this paper, a new application level protocol,
branched domino reaction has been designed for the synthesis of quinolone B. The hypothesis was proven by switching benzoylacetic acid
ethyl ester to 3-(2-fluoro-phenyl)-3-oxo-propionic acid ethyl ester,
namely, introducing fluoro at the benzene ortho position (Table 3). To our joy, the
yield of this reaction is high; this result will provide the possibility
for subsequent industrial development to produce the QNSs. Interestingly,
the use of anilines with electron-withdrawing functionalities afforded
the corresponding products in higher yields. However, the use of anilines
with electron-donating functionalities turned out to be less effective.
A similar trend, which is typically rationalized by the nucleophilic
aromatic substitution (C–N bond formation), has been observed
before; the electronic nature of the aniline significantly influences
the yield of the product.

Table 3 Substrate Scope of
the Reaction for
Quinolones Ba,b
a Reaction conditions,
unless stated
otherwise: 1 (1.0 mmol), 2 (1.2 mmol), and 3 (1.0 mmol) under solvent- and catalyst-free conditions at
130 °C in one-pot reacted for 24 h.

b Isolated yield based on arylamine 3, nonchromatographic
purification.

The floxacin
of QNSs has a lot of similarity in the mother structure,
and the old route of its synthesis has many drawbacks such as more
steps, time consuming, more foreign matter, and poor yield. To illustrate
the utility of the synthetic strategy and solve these problems, picking
existing pharmaceutical sarafloxacin as an example, we designed a
new linear domino protocol for the highly efficient and sustainable
synthesis of sarafloxacin (Scheme 2). The first key step used three inexpensive starting
materials ethyl 2,4,5-trifluorobenzoylacetate, triethyl orthoformate,
and 4-fluoroaniline at 130 °C under solvent- and catalyst-free
conditions reacted for 24 h to provide the quinolone scaffold. Piperazine
was then added with acetonitrile as the solvent, without the catalyst
to produce the crude adduct through a nucleophilic substitution reaction.
Next, addition of 50% NaOH promoted the hydrolysis of the ester group
to afford sarafloxacin, which was purified by acid/base extraction,
and we obtained up to 82% yield. The properties of synthetic sarafloxacin
were identical to those reported in the literature (1H
and 13C NMR spectra).13

Scheme 2 Sustainable Synthesis of Sarafloxacin by the Linear Domino Protocol
It should be noted that all
of the synthetic transformations of
this new domino reaction can be performed in one reaction vessel.
The process involves multiple reaction couplings and no purification
by column chromatography, making it environmentally sustainable. The
catalytic reagent used in the present total synthesis contained only
NaOH, and the reaction solvents were water and acetonitrile. No special
care is needed to exclude water or air. We have also observed that
the process is not sensitive to scale-up, which is essential for its
future translation from laboratory research to industrial applications.
The synthetic route itself is different from previous ones and should
enable the synthesis of a wide variety of novel derivatives. This
protocol will be valuable for the discovery of antibiotics, and we
hope that the further refinement of this method will make useful contribution
to the fields of both medicinal chemistry and natural product synthesis.

In our hypothesis, these elegant domino processes integrated consecutive
condensation and nucleophile-attacked, nucleophile substitution, and
ring-closing sequences to form C=C bond and C–N bonds.
Notably, the intermediate enamino diester was generated in situ, and
further sequential reactions with other substrates resulted in the
construction of different organic compounds via different domino processes.
On the basis of the experimental results (see Supporting Information), postulated mechanisms for the two
domino reactions are shown in Scheme 3. The dicarbonyl compound reacts with triethyl orthoformate
to form intermediate A (C=C bond formation) which
then reacts with an amine via a substitution reaction to yield the
intermediate enamino diester B. Here, if the benzene
ring of the intermediate D has a halogen substituent
at the ortho position, it simultaneously undergoes nucleophilic aromatic
substitution to yield the final product B. If not, intermediate C will undergo intramolecular cyclization with diphenyl ether
as the cyclization reagent via a Friedel–Crafts reaction to
afford quinolone A.

Scheme 3 Postulated Domino Protocol Mechanisms
for the Formation of Quinolones
Conclusions
As a conclusion, two sustainable and clean
procedures for the preparation
of a library of quinolones and an environmentally sustainable target
synthesis protocol for sarafloxacin have been presented. The simple
operation, moderate to excellent yields with fine substrate tolerance,
and sustainability of the present method make it a highly useful complementary
tool in the synthesis of the novel floxacin of QNSs. We believe that
such efficient and clean methodologies could have great application
potential to optimization of the synthetic procedure of quinolone.
The further synthetic applications of these reactions to the construction
of quinolone-containing drugs or natural products and the subsequent
biological evaluation of the synthesized compounds are currently underway
in our laboratory.

Experimental Section
General Methods
All reagents were obtained from commercial
suppliers and used without further purification. All compounds were
characterized by full spectroscopic data. The 1H and 13C nuclear magnetic resonance (NMR) spectra were recorded
on Bruker Avance III 400 MHz (1H NMR: 400 MHz, 13C NMR: 100 MHz) using CDCl3, DMSO-d6, and F3CCOOD as solvents with tetramethylsilane
as the internal standard (when CDCl3, DMSO-d6, and so forth were unable to dissolve the product, we
chose F3CCOOD as a solvent). Chemical shifts are given
in ppm (δ) referenced to CDCl3 with 7.26 for 1H and 77.16 for 13C, DMSO-d6 with 2.50 for 1H and 39.52 for 13C,
and F3COOD with 11.50 for 1H and 164.2 for 13C. The signals are abbreviated as follows: s, singlet; d,
doublet; t, triplet; q, quartet; and m, multiplet, and the coupling
constants are expressed in hertz. The melting points were determined
on a Tech X-5 melting point apparatus and are uncorrected. IR spectra
(KBr pellet) were detected by a Thermo Nicolet S10 Fourier transform
infrared (FTIR) instrument. High-resolution mass spectrometry (HRMS)
measurements were performed on an Agilent LC/MSD TOF instrument. X-ray
crystallography patterns were obtained from a TTRAX III X-ray diffractometer.

General Procedure for the Synthesis of Quinolones A
Domino process 1: dicarbonyl compound (2.0 mmol), triethyl
orthoformate (2.25 mmol), and amine (2.0 mmol) were placed inside
a 10 mL high-pressure reaction tube, and then, the tube was closed.
The mixture was stirred at 130 °C, and the reaction was monitored
by thin-layer chromatography (TLC). Domino process 2: when the reaction
completed as indicated by TLC, diphenyl ether reflux was added and
reacted for 0.75 h to give the crude product. Purge process: the crude
product was further washed by PE (petroleum ether), EtOAc, and MeOH
to give pure quinolones A. Diphenyl ether and elution
solvents can be distilled to recover and reused throughout the whole
processes.

3-Benzoylquinolin-4(1H)-one (1a)
White solid; yield 86%; mp 260–262 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.47 (br s, 1H), 8.36 (s, 1H), 8.16 (dd, 1H, J = 1.32, 1.28 Hz), 7.76–7.72 (m, 3H), 7.68 (d, 1H, J = 7.12 Hz), 7.60–7.56 (m, 1H), 7.48–7.41
(m, 3H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 194.8, 174.9, 143.7, 139.9, 139.0, 132.9,
132.6, 129.5, 128.5, 127.5, 126.0, 125.0, 119.9, 119.3; IR (KBr) νmax (cm–1): 3445, 2330, 1644, 1554, 1473,
1440, 1371, 1295, 1068, 857, 758, 624; HRMS (ESI-TOF+) m/z: calcd for C16H12NO2+ [(M + H)+], 250.0863; found,
250.0862.

3-Benzoyl-6-fluoroquinolin-4(1H)-one (1b)
White solid; yield 74%; mp >300
°C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.61 (br s, 1H), 8.39 (s, 1H), 7.80–7.72 (m, 4H),
7.68–7.63 (m, 1H), 7.60–7.56 (m, 1H), 7.48–7.44
(m, 2H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 194.6, 174.0, 173.9, 160.7, 158.3, 143.7,
138.8, 136.6, 132.7, 129.5, 128.9, 128.8, 128.5, 122.2, 122.1, 121.7,
121.5, 119.1, 110.3, 110.1.

3-Benzoyl-6-chloroquinolin-4(1H)-one (1c)
White solid; yield 71%;
mp >300 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.64 (br s, 1H), 8.40 (s, 1H), 8.05 (d, 1H, J = 2.24 Hz), 7.79 (m, 1H), 7.72 (t, 3H, J = 8.36
Hz), 7.59 (t, 1H, J = 7.28 Hz), 7.46 (t, 2H, J = 7.60 Hz); 13C NMR (100 MHz, F3COOD, ppm): δ 201.9, 176.9, 150.0, 141.2, 140.0, 139.6, 137.0,
136.1, 131.4, 131.1, 126.3, 123.7, 123.7.

3-Benzoyl-6-bromoquinolin-4(1H)-one (1d)
White solid; yield 67%;
mp >300 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.60 (br s, 1H), 8.39 (d, 1H, J = 5.32 Hz),
8.19 (s, 1H), 7.91 (d, 1H, J = 8.68 Hz), 7.74–7.44
(m, 6H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 194.5, 173.6, 143.9, 138.9, 138.6, 135.6,
132.8, 129.5, 128.9, 128.5, 128.1, 121.9, 120.2, 117.7.

3-Benzoyl-6-iodoquinolin-4(1H)-one (1e)
Pale yellow solid; mp
>300 °C; yield 66%; 1H NMR (400 MHz, DMSO-d6, ppm): δ
12.53 (br s, 1H), 8.39 (dd, 2H, J = 2.00, 4.88 Hz),
8.03 (dd, 1H, J = 2.04, 2.04 Hz), 7.71 (t, 2H, J = 7.04 Hz), 7.59–7.56 (m, 1H), 7.49–7.43
(m, 3H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 194.5, 173.4, 143.9, 141.0, 139.2, 138.6,
134.4, 132.8, 129.5, 129.1, 128.5, 121.7, 120.4, 89.8.

3-Benzoyl-6-nitroquinolin-4(1H)-one (1f)
Brown solid; yield 82%;
mp 235–238 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.90 (br d, 1H, J = 4.00 Hz), 8.85 (d, 1H, J = 2.64 Hz), 8.52 (dd, 1H, J = 2.68, 2.72
Hz), 8.47 (s, 1H), 7.86 (d, 1H, J = 9.12 Hz), 7.78–7.76
(m, 2H), 7.64–7.59 (m, 1H), 7.50–7.46 (m, 2H); 13C NMR (100 MHz, DMSO-d6, ppm):
δ 194.0, 174.4, 144.6, 144.0, 143.8, 138.2, 133.1, 129.6, 128.6,
127.0, 126.7, 122.3, 121.3, 121.2; IR (KBr) νmax (cm–1): 3444, 2338, 1662, 1585, 1510, 1474, 1345, 1203,
1080, 905, 843, 746, 563; HRMS (ESI-TOF+) m/z: calcd for C16H11N2O4+ [(M + H)+], 295.0713;
found, 295.0716.

3-Benzoyl-6-(trifluoromethyl)quinolin-4(1H)-one
(1g)
White solid; yield 78%; mp >300 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.75 (br s, 1H), 8.45 (s, 1H), 8.37 (d, 1H, J = 1.04 Hz), 8.05 (dd, 1H, J = 2.08, 2.08 Hz), 7.87
(d, 1H, J = 8.68 Hz), 7.77–7.74 (m, 2H), 7.61–7.57
(m, 1H), 7.48–7.44 (m, 2H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 194.3, 174.3, 144.5, 142.2,
138.4, 132.9, 129.6, 128.9, 128.6, 126.8, 123.5, 123.4, 121.0; IR
(KBr) νmax (cm–1): 3446, 1645,
1584, 1526, 1444, 1368, 1332, 1294, 1254, 1112, 1008, 842, 783, 699;
HRMS (ESI-TOF+) m/z:
calcd for C17H11F3NO2+ [(M + H)+], 318.0736; found, 318.0739.

6-Acetyl-3-benzoylquinolin-4(1H)-one (1h)
Pale-brown solid; yield
80%; mp >300 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.67 (br s, 1H), 8.68 (d, 1H, J = 1.92 Hz),
8.40 (s, 1H), 8.24 (dd, 1H, J = 2.00, 2.00 Hz), 7.76–7.72
(m, 3H), 7.61–7.57 (m, 1H), 7.47 (t, 2H, J = 15.2 Hz), 2.65 (s, 3H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 197.2, 194.5, 174.9, 144.1,
142.8, 138.5, 133.0, 132.9, 131.5, 129.5, 128.6, 127.4, 126.7, 121.0,
119.8, 27.1; IR (KBr) νmax (cm–1): 3445, 2360, 1675, 1644, 1521, 1359, 1294, 1069, 1008, 854, 780,
696; HRMS (ESI-TOF+) m/z: calcd for C18H14NO3+ [(M + H)+], 292.0968; found, 292.0969.

3-Benzoyl-6-methylquinolin-4(1H)-one (1i)
White solid; yield 64%;
mp >300 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.37 (br s, 1H), 8.29 (s, 1H), 7.91 (d, 1H, J = 0.76 Hz), 7.72–7.70 (m, 2H), 7.58–7.54 (m, 3H),
7.46–7.42 (m, 2H), 2.42 (s, 3H); 13C NMR (100 MHz,
DMSO-d6, ppm): δ 194.9, 174.7, 143.2,
138.9, 137.8, 134.5, 134.2, 132.6, 129.5, 128.4, 127.4, 125.3, 119.6,
119.2, 21.2.

3-Benzoyl-6-ethylquinolin-4(1H)-one (1j)
White solid; yield 56%; mp 282–284
°C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.40 (br s, 1H), 8.30 (s, 1H), 7.93 (d, 1H, J = 0.84 Hz), 7.73–7.70 (m, 2H), 7.62–7.54 (m, 3H),
7.46–7.42 (m, 2H), 2.75 (dd, 2H, J = 7.52,
7.56 Hz), 1.22 (t, 3H, J = 15.2 Hz); 13C NMR (100 MHz, DMSO-d6, ppm): δ
194.9, 174.7, 143.2, 140.7, 139.0, 138.1, 133.2, 132.5, 130.5, 129.5,
128.4, 127.5, 123.9, 119.6, 119.3, 119.0, 28.3, 15.9.

3-Benzoyl-6-isopropylquinolin-4(1H)-one (1k)
White solid; yield 69%;
mp 265–267 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.41 (br s, 1H), 8.31 (s, 1H), 7.96 (d, 1H, J = 1.96 Hz), 7.73–7.70 (m, 2H), 7.66 (dd, 1H, J = 2.04, 2.04 Hz), 7.61–7.54 (m, 2H), 7.46–7.42 (m,
2H), 3.05–2.98 (m, 1H), 1.25 (dd, 6H, J =
6.92 Hz); 13C NMR (100 MHz, DMSO-d6, ppm): δ 194.9, 174.8, 145.3, 143.3, 139.0, 138.2,
132.5, 131.9, 130.4, 129.5, 128.4, 127.4, 122.3, 119.6, 119.4, 119.0,
33.6, 24.2.

3-Benzoyl-6-(tert-butyl)quinolin-4(1H)-one (1l)
White solid; yield 73%;
mp >300 °C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.43 (br s, 1H), 8.32 (s, 1H), 8.10
(d, 1H, J = 2.24 Hz), 7.86 (dd, 1H, J = 2.32, 2.32 Hz), 7.74–7.71 (m, 2H), 7.63 (d, 1H, J = 8.72 Hz), 7.59–7.55 (m, 1H), 7.47–7.43
(m, 2H), 1.34 (s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 195.0, 174.9, 147.6, 143.2, 139.1, 137.9,
132.5, 131.0, 129.4, 128.4, 127.0, 121.0, 119.7, 119.2, 34.9, 31.4;
IR (KBr) νmax (cm–1): 3444, 3071,
2961, 1649, 1558, 1489, 1357, 1322, 1068, 838, 700, 601; HRMS (ESI-TOF+) m/z: calcd for C20H20NO2+ [(M + H)+], 306.1489;
found, 306.1486.

3-Benzoyl-6-methoxyquinolin-4(1H)-one (1m)
White solid; yield 47%; mp >300
°C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.44 (br s, 1H), 8.28 (s, 1H), 7.72 (d, 2H, J = 8.04 Hz), 7.63 (d, 1H, J = 8.96 Hz), 7.58–7.52
(m, 2H), 7.44 (t, 2H, J = 7.56 Hz), 7.38 (dd, 1H, J = 2.76, 2.84 Hz), 3.84 (s, 3H); 13C NMR (100
MHz, DMSO-d6, ppm): δ 195.0, 174.2,
157.0, 142.5, 139.1, 134.3, 132.5, 129.5, 128.7, 128.4, 123.0, 121.0,
118.8, 105.6, 55.9.

3-Benzoyl-8-bromoquinolin-4(1H)-one (1n)
White solid; yield 76%; mp 248–250
°C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 11.76 (br s, 1H), 8.19–8.14 (m, 2H), 8.10 (dd, 1H, J = 1.28, 1.32 Hz), 7.75–7.73 (m, 2H), 7.62–7.57
(m, 1H), 7.49–7.45 (m, 2H), 7.37 (t, 1H, J = 7.84 Hz); 13C NMR (100 MHz, DMSO-d6, ppm): δ 194.2, 174.4, 144.2, 138.5, 137.5, 136.5,
132.9, 129.5, 129.0, 128.6, 126.0, 125.8, 120.4, 112.3; IR (KBr) νmax (cm–1): 3445, 2360, 1646, 1523, 1432,
1328, 1278, 1069, 1009, 162, 699, 547; HRMS (ESI-TOF+) m/z: calcd for C16H11BrNO2+ [(M + H)+], 327.9968; found,
327.9968.

3-Benzoyl-8-methylquinolin-4(1H)-one (1o)
White solid; yield 70%; mp 270–272
°C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 11.77 (br s, 1H), 8.18 (s, 1H), 8.02 (d, 1H, J = 8.00 Hz), 7.73 (t, 2H, J = 15.28 Hz), 7.59–7.56
(m, 2H), 7.46 (t, 2H, J = 7.68 Hz), 7.32 (t, 1H, J = 7.72 Hz); 13C NMR (100 MHz, DMSO-d6, ppm): δ 194.7, 175.1, 143.5, 138.8,
138.4, 133.7, 132.6, 129.5, 128.5, 127.6, 127.5, 124.6, 123.9, 119.8,
17.5; IR (KBr) νmax (cm–1): 3447,
2360, 1645, 1538, 1450, 1423, 1345, 1229, 1073, 1015, 793, 768, 553;
HRMS (ESI-TOF+) m/z:
calcd for C17H14NO2+ [(M
+ H)+], 264.1019; found, 264.1017.

3-Benzoyl-8-isopropylquinolin-4(1H)-one (1p)
White solid; yield 66%;
mp 201–203 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 11.80 (br d, 1H, J = 6.44 Hz), 8.19 (d, 1H, J = 6.76 Hz), 8.05 (dd, 1H, J = 1.04, 1.08
Hz), 7.75–7.68 (m, 3H), 7.60–7.56 (m, 1H), 7.48–7.37
(m, 3H), 3.52 (m, 1H), 1.33 (d, 6H, J = 6.72 Hz); 13C NMR (100 MHz, DMSO-d6, ppm):
δ 194.6, 175.1, 143.5, 138.8, 137.7, 137.0, 132.6, 130.4, 129.5,
129.1, 128.4, 127.9, 124.9, 123.8, 119.5, 119.0, 26.9, 23.4; IR (KBr)
νmax (cm–1): 3448, 1646, 1540,
1431, 1388, 1323, 1233, 1196, 1072, 863, 770, 712, 586; HRMS (ESI-TOF+) m/z: calcd for C19H18NO2+ [(M + H)+], 292.1332;
found, 292.1329.

3-Benzoyl-8-methoxyquinolin-4(1H)-one (1q)
Brown solid; yield 62%; mp 238–240
°C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.06 (br s, 1H), 8.11 (s, 1H), 7.74–7.68 (m, 3H),
7.59–7.56 (m, 1H), 7.46 (t, 2H, J = 7.72 Hz),
7.38–7.34 (m, 2H), 4.03 (s, 3H); 13C NMR (100 MHz,
DMSO-d6, ppm): δ 194.7, 174.6, 149.2,
142.9, 138.9, 132.6, 130.3, 129.5, 128.5, 128.4, 124.9, 120.1, 117.1,
112.7, 56.8.

3-Benzoyl-7-bromoquinolin-4(1H)-one (1r)
White solid; yield 64%; mp >300
°C; 1H NMR (400 MHz, F3CCOOD, ppm): δ
9.15 (s,
1H), 8.50 (d, 1H, J = 8.84 Hz), 8.28 (s, 1H), 8.02
(d, 1H, J = 8.20 Hz), 7.71–7.54 (m, 5H); 13C NMR (100 MHz, F3CCOOD, ppm): δ 220.2,
178.0, 151.0, 141.7, 137.3, 137.1, 136.6, 136.3, 131.6, 131.2, 128.5,
125.2, 121.6; IR (KBr) νmax (cm–1): 3444, 1643, 1524, 1370, 1070, 1013, 847, 695, 547; HRMS (ESI-TOF+) m/z: calcd for C16H11BrNO2+ [(M + H)+],
327.9968; found, 327.9967.

3-Benzoyl-7-methylquinolin-4(1H)-one (1s)
White solid; yield 58%;
mp >300 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.34 (br t, 1H, J = 3.36 Hz), 8.29 (d, 1H, J = 8.24 Hz), 8.02 (d, 1H, J = 8.24 Hz),
7.72–7.70 (m, 2H), 7.59–7.55 (m, 1H), 7.47–7.42
(m, 3H), 7.25 (dd, 1H, J = 1.61, 1.12 Hz), 2.45 (s,
3H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 194.8, 174.7, 143.5, 143.3, 140.0, 139.0, 132.6,
129.5, 129.3, 128.5, 128.4, 126.6, 125.9, 125.4, 119.8, 118.5, 21.7;
IR (KBr) νmax (cm–1): 3448, 3067,
1644, 1578, 1532, 1477, 1324, 1203, 1075, 1014, 848, 770, 693; HRMS
(ESI-TOF+) m/z: calcd
for C17H14NO2+ [(M + H)+], 264.1019; found, 264.1016.

3-Benzoyl-7-methoxyquinolin-4(1H)-one (1t)
Pale-Brown solid; yield
67%; mp >300 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.23 (br s, 1H), 8.27 (s, 1H), 8.03 (d, 1H, J = 8.92 Hz), 7.72–7.70 (m, 2H), 7.59–7.54 (m, 1H),
7.47–7.43 (m, 2H), 7.05–7.00 (m, 2H), 3.88 (s, 3H); 13C NMR (100 MHz, DMSO-d6, ppm):
δ 194.8, 174.3, 162.8, 143.5, 141.7, 139.0, 132.6, 129.5, 128.4,
127.8, 121.5, 119.9, 114.6, 100.5, 56.0; IR (KBr) νmax (cm–1): 3446, 1643, 1549, 1475, 1367, 1270, 1068,
1015, 950, 866, 775, 725, 634; HRMS (ESI-TOF+) m/z: calcd for C17H14NO3+ [(M + H)+], 280.0968; found,
280.0962.

3-Benzoyl-6,7-dichloroquinolin-4(1H)-one (1u)
White solid; yield 84%;
mp >300 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.53 (br s, 1H), 8.30 (s, 1H), 7.92 (d, 1H, J = 8.96 Hz), 7.76–7.74 (m, 2H), 7.64–7.57 (m, 2H),
7.49–7.45 (m, 2H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 194.6, 173.9, 142.2, 141.1,
138.5, 133.4, 132.8, 130.5, 129.5, 129.3, 128.6, 124.7, 122.2, 119.8;
IR (KBr) νmax (cm–1): 3444, 1642,
1576, 1544, 1446, 1367, 1290, 1204, 1070, 1009, 801, 777, 700, 634;
HRMS (ESI-TOF+) m/z:
calcd for C16H10Cl2NO2+ [(M + H)+], 318.0083; found, 318.0082.

3-Benzoyl-6,7-dimethylquinolin-4(1H)-one (1v)
Pale-gray solid; yield
77%; mp 230–232
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 11.36 (br d, 1H, J = 3.76 Hz), 8.06
(d, 1H, J = 8.96 Hz), 7.72 (t, 2H, J = 7.00 Hz), 7.58–7.55 (m, 1H), 7.45 (t, 2H, J = 7.72 Hz), 7.40 (d, 1H, J = 7.48 Hz), 7.01 (d,
1H, J = 7.48 Hz), 2.68 (s, 3H), 2.46 (s, 3H); 13C NMR (100 MHz, DMSO-d6, ppm):
δ 195.0, 178.1, 141.9, 139.8, 138.9, 137.9, 132.8, 132.5, 129.3,
128.5, 127.0, 125.8, 124.8, 121.5, 23.6, 17.6; IR (KBr) νmax (cm–1): 3446, 1653, 1625, 1544, 1450,
1406, 1325, 1206, 1069, 999, 854, 789, 689, 557; HRMS (ESI-TOF+) m/z: calcd for C18H16NO2+ [(M + H)+], 278.1176;
found, 278.1172.

3-Benzoyl-6-benzylquinolin-4(1H)-one (1w)
White solid; yield 83%; mp 284–286
°C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.43 (br s, 1H), 8.31 (s, 1H), 7.95 (d, 1H, J = 0.92 Hz), 7.71 (t, 2H, J = 7.08 Hz), 7.64–7.54
(m, 3H), 7.44 (t, 2H, J = 7.72 Hz), 7.32–7.25
(m, 4H), 7.22–7.18 (m, 1H), 4.08 (s, 2H); 13C NMR
(100 MHz, DMSO-d6, ppm): δ 194.8,
174.7, 143.3, 141.3, 138.9, 138.4, 138.3, 133.8, 132.6, 129.5, 129.2,
129.0, 128.4, 127.5, 126.5, 125.2, 119.8, 119.5; IR (KBr) νmax (cm–1): 3445, 1639, 1578, 1522, 1487,
1358, 1328, 1291, 1199, 1069, 862, 749, 696, 574; HRMS (ESI-TOF+) m/z: calcd for C23H17NO2+ [(M + H)+], 340.1332;
found, 340.1328.

3-Benzoyl-6-(4-chlorophenoxy)quinolin-4(1H)-one
(1x)
White solid; yield 80%; mp 291–293
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.57 (br s, 1H), 8.36 (s, 1H), 7.76–7.70
(m, 3H), 7.58–7.51 (m, 3H), 7.49–7.42 (m, 4H), 7.14–7.10
(m, 2H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 194.7, 174.0, 155.6, 154.2, 143.4, 138.9,
136.1, 132.6, 130.5, 129.4, 128.7, 128.4, 128.4, 125.0, 121.8, 121.4,
119.1, 112.5; IR (KBr) νmax (cm–1): 3448, 2326, 1641, 1525, 1477, 1368, 1330, 1294, 1236, 1088, 1009,
833, 698; HRMS (ESI-TOF+) m/z: calcd for C22H15ClNO3+ [(M + H)+], 376.0735; found, 376.0733.

3-Benzoylbenzo[h]quinolin-4(1H)-one (1y)
White solid; yield 73%; mp 276–278
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.75 (br s, 1H), 8.74 (t, 1H, J = 3.12 Hz), 8.29 (s, 1H), 8.16–8.10 (m, 2H), 7.88 (d, 1H, J = 8.84 Hz), 7.84–7.79 (m, 4H), 7.61 (t, 1H, J = 7.36 Hz), 7.49 (t, 2H, J = 7.76 Hz); 13C NMR (100 MHz, DMSO-d6, ppm):
δ 194.8, 174.5, 141.9, 138.5, 135.0, 133.0, 129.6, 129.3, 128.6,
127.7, 125.2, 122.5, 122.3, 122.1; IR (KBr) νmax (cm–1): 3442, 1644, 1599, 1550, 1420, 1328, 1270, 1183,
1067, 1009, 863, 801, 763, 695, 534; HRMS (ESI-TOF+) m/z: calcd for C20H15NO2+ [(M + H)+], 300.1019; found,
300.1016.

3-Benzoylpyrido[2,3-g]quinolin-4(1H)-one (1za)
White solid; yield 81%;
mp >300
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.85 (br s, 1H), 10.40 (d, 1H, J = 8.28 Hz), 8.93 (dd, 1H, J = 1.40, 1.40 Hz), 8.39
(s, 1H), 8.28 (d, 1H, J = 9.16 Hz), 7.99 (d, 1H, J = 9.20 Hz), 7.82 (d, 2H, J = 7.32 Hz),
7.66–7.58 (m, 2H), 7.47 (t, 2H, J = 7.64 Hz); 13C NMR (100 MHz, DMSO-d6, ppm):
δ 195.4, 177.2, 149.8, 145.6, 140.6, 140.0, 138.5, 135.2, 134.5,
133.0, 129.5, 128.7, 126.9, 124.7, 123.4, 122.5, 119.3; IR (KBr) νmax (cm–1): 3449, 1654, 1597, 1559, 1528,
1368, 1310, 1284, 1206, 1075, 1014, 848, 553; HRMS (ESI-TOF+) m/z: calcd for C19H13N2O2+ [(M + H)+], 301.0972; found, 301.0971.

3-Benzoylbenzo[b][1,5]naphthyridin-4(1H)-one (1zb)
Yellow solid; yield 75%;
mp >300 °C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 13.13 (br s, 1H), 9.92 (dd, 1H, J = 1.04, 1.16 Hz), 9.31 (s, 1H), 8.49 (s, 1H), 8.46 (dd,
1H, J = 0.96, 0.84 Hz), 7.84–7.79 (m, 2H),
7.76–7.72 (m, 2H), 7.50 (t, 2H, J = 7.76 Hz); 13C NMR (100 MHz, DMSO-d6, ppm):
δ 195.1, 176.6, 145.6, 144.1, 140.7, 138.2, 134.7, 133.1, 129.7,
129.5, 129.1, 128.8, 126.4, 126.0, 124.4, 123.0; IR (KBr) νmax (cm–1): 3446, 2329, 1643, 1495, 1417,
1272, 1068, 998, 816, 543; HRMS (ESI-TOF+) m/z: calcd for C19H13N2O2+ [(M + H)+], 301.0972;
found, 301.0970.

3-Pivaloylquinolin-4(1H)-one
(2a)
White solid; yield 70%; mp 198–201
°C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.21 (br d, 1H, J = 4.76 Hz), 8.17 (dd,
1H, J = 1.24, 1.24 Hz), 7.04 (d, 1H, J = 6.32 Hz), 7.70–7.66 (m, 1H), 7.60 (d, 1H, J = 7.88 Hz), 7.40–7.36 (m, 1H), 1.23 (s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm): δ
210.3, 174.5, 140.7, 139.7, 132.6, 126.9, 125.8, 124.5, 123.1, 119.0,
118.9, 44.3, 26.7; IR (KBr) νmax (cm–1): 3444, 2327, 1655, 1622, 1559, 1468, 1437, 1351, 1300, 1068, 845,
791, 763, 545; HRMS (ESI-TOF+) m/z: calcd for C14H16NO2+ [(M + H)+], 230.1176; found, 230.1172.

6-Fluoro-3-pivaloylquinolin-4(1H)-one (2b)
White solid; yield 81%;
mp 209–211 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.38 (br s, 1H), 8.09 (s, 1H), 7.83 (dd, 1H, J = 2.92, 2.92 Hz), 7.71–7.67 (m, 1H), 7.63–7.58 (m,
1H), 1.23 (s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 210.1, 173.6, 173.5, 160.5, 158.1, 140.9,
136.4, 128.2, 128.1, 122.2, 121.8, 121.7, 121.5, 121.3, 110.1, 109.9,
44.3, 26.6; IR (KBr) νmax (cm–1): 3127, 2970, 1658, 1588, 1563, 1531, 1482, 1401, 1361, 1300, 1188,
1103, 1010, 920, 801, 565; HRMS (ESI-TOF+) m/z: calcd for C14H15FNO2+ [(M + H)+], 248.1081; found, 248.1079.

6-Chloro-3-pivaloylquinolin-4(1H)-one (2c)
White solid; yield 75%; mp 260–262 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.38 (br s, 1H), 8.03 (s, 1H), 8.02 (s, 1H), 7.68 (dd, 1H, J = 2.44, 2.40 Hz), 7.59 (d, 1H, J = 8.84
Hz), 1.17 (s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 210.0, 173.2, 141.0, 138.4, 132.7, 130.4,
129.2, 127.8, 124.8, 123.2, 121.4, 119.0, 44.3, 26.7; HRMS (ESI-TOF+) m/z: calcd for C14H15ClNO2+ [(M + H)+],
264.0876; found, 264.0873.

6-Bromo-3-pivaloylquinolin-4(1H)-one (2d)
White solid; yield 78%;
mp 279–281 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.37 (br d, 1H, J = 5.4 Hz), 8.25 (d, 1H, J = 2.32 Hz), 8.10 (d, 1H, J = 6.28 Hz),
7.86 (dd, 1H, J = 2.36, 2.36 Hz), 7.60 (d, 1H, J = 8.80 Hz), 1.24 (s, 9H); 13C NMR (100 MHz,
DMSO-d6, ppm): δ 210.0, 173.2, 140.9,
138.7, 135.3, 128.2, 128.0, 123.3, 121.6, 117.2, 44.3, 26.7; IR (KBr)
νmax (cm–1): 3445, 1665, 1578,
1518, 1466, 1393, 1299, 1068, 1006, 894, 823, 648, 559; HRMS (ESI-TOF+) m/z: calcd for C14H15BrNO2+ [(M + H)+],
308.0281; found, 308.0280.

6-Nitro-3-pivaloylquinolin-4(1H)-one (2e)
White solid; yield 80%;
mp 260–262 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.61 (br s, 1H), 8.82 (d, 1H, J = 2.60 Hz),
8.14–8.10 (m, 2H), 7.73 (d, 1H, J = 9.12 Hz),
1.17 (s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 209.7, 174.1, 143.7, 143.6, 141.3, 126.7,
125.8, 125.5, 124.3, 122.3, 120.9, 112.8, 44.5, 26.6; IR (KBr) νmax (cm–1): 3447, 1664, 1614, 1518, 1469,
1360, 1300, 1076, 1007, 825, 654, 561; HRMS (ESI-TOF+) m/z: calcd for C14H15N2O4+ [(M + H)+], 264.0786;
found, 264.0784.

3-Pivaloyl-6-(trifluoromethyl)quinolin-4(1H)-one (2f)
White solid; yield 83%;
mp 274–276
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.53 (br s, 1H), 8.41 (d, 1H, J = 0.92 Hz), 8.15 (s, 1H), 8.01 (dd, 1H, J = 2.61,
2.12 Hz), 7.81 (d, 1H, J = 8.68 Hz), 1.23 (s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm):
δ 209.9, 173.9, 142.0, 141.3, 128.6, 128.5, 126.1, 125.9, 124.9,
124.5, 124.1, 123.4, 123.4, 123.3, 123.2, 120.7, 44.4, 26.6; IR (KBr)
νmax (cm–1): 3168, 1669, 1616,
1566, 1472, 1408, 1327, 1203, 1120, 844, 605; HRMS (ESI-TOF+) m/z: calcd for C15H15F3NO2+ [(M + H)+], 298.1049; found, 298.1043.

6-Acetyl-3-pivaloylquinolin-4(1H)-one (2g)
Yellow solid; yield 66%;
mp 244–246 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.47 (br d, 1H, J = 8.68 Hz), 8.73 (d, 1H, J = 1.88 Hz), 8.20 (dd, 1H, J = 2.04, 2.04
Hz), 8.10 (d, 1H, J = 6.16 Hz), 7.68 (d, 1H, J = 8.72 Hz), 2.66 (s, 3H), 1.24 (s, 9H); 13C
NMR (100 MHz, DMSO-d6, ppm): δ 210.2,
197.2, 174.6, 142.6, 140.9, 132.6, 131.1, 127.5, 125.9, 124.1, 119.5,
44.4, 27.0, 26.7; IR (KBr) νmax (cm–1): 3446, 1660, 1584, 1516, 1473, 1363, 1070, 831, 554; HRMS (ESI-TOF+) m/z: calcd for C16H18NO3+ [(M + H)+], 272.1281;
found, 272.1281.

6-Methyl-3-pivaloylquinolin-4(1H)-one (2h)
White solid; yield 52%; mp 243–246
°C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.14 (br d, 1H, J = 5.52 Hz), 7.99 (d, 1H, J = 2.36 Hz), 7.95 (s, 1H), 7.51–7.50 (m, 2H), 2.41
(s, 3H), 1.23 (s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 210.4, 174.3, 140.3, 137.7, 133.9, 126.8,
125.1, 122.8, 118.8, 44.3, 26.7, 21.2; IR (KBr) νmax (cm–1): 3445, 1644, 1551, 1485, 1388, 1296, 1069,
804, 573; HRMS (ESI-TOF+) m/z: calcd for C15H18NO2+ [(M + H)+], 224.1332; found, 224.1327.

6-Ethyl-3-pivaloylquinolin-4(1H)-one (2i)
White solid; yield 43%;
mp 170–173 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.19 (br d, 1H, J = 6.04 Hz), 8.02 (d, 1H, J = 6.36 Hz), 7.98 (s, 1H), 7.57–7.51 (m, 2H), 2.74
(dd, 2H, J = 7.56, 7.56 Hz), 1.24 (s, 9H), 1.21 (m,
3H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 210.4, 174.3, 140.4, 140.2, 137.9, 132.9, 126.9,
123.8, 122.8, 118.9, 44.2, 28.3, 26.7, 15.9; IR (KBr) νmax (cm–1): 3442, 2961, 1659, 1567, 1486,
1385, 1296, 1066, 831, 568; HRMS (ESI-TOF+) m/z: calcd for C16H20NO2+ [(M + H)+], 258.1489; found, 258.1487.

6-(tert-Butyl)-3-pivaloylquinolin-4(1H)-one (2j)
White solid; yield 49%;
mp 255–257 °C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.19 (br d, 1H, J = 6.16 Hz), 8.13 (d, 1H, J = 2.24 Hz), 8.02 (d,
1H, J = 6.4 Hz), 7.80 (dd, 1H, J = 2.20, 2.24 Hz), 7.57 (d, 1H, J = 7.56 Hz), 1.32
(s, 9H), 1.24 (s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 210.4, 174.5, 147.1, 140.5, 137.7, 130.7,
126.4, 122.9, 120.9, 118.8, 44.2, 34.9, 31.4, 26.7; IR (KBr) νmax (cm–1): 3446, 3085, 2969, 1689, 1551,
1488, 1358, 1202, 1071, 1009, 839, 697; HRMS (ESI-TOF+) m/z: calcd for C18H24NO2+ [(M + H)+], 286.1802; found,
286.1797.

6-Methoxy-3-pivaloylquinolin-4(1H)-one (2k)
White solid; yield 56%; mp 198–200
°C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.21 (br d, 1H, J = 5.60 Hz), 8.00 (d, 1H, J = 6.40 Hz), 7.58–7.55 (m, 2H), 7.34 (dd, 1H, J = 2.92, 2.96 Hz), 3.84 (s, 3H), 1.24 (s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm): δ
210.4, 173.7, 156.6, 139.9, 134.2, 128.1, 122.9, 121.9, 120.7, 105.4,
55.8, 44.2, 26.7; IR (KBr) νmax (cm–1): 3445, 1664, 1548, 1514, 1364, 1307, 1071, 1006, 861, 570; HRMS
(ESI-TOF+) m/z: calcd
for C15H18NO3+ [(M + H)+], 260.1281; found, 260.1283.

8-Bromo-3-pivaloylquinolin-4(1H)-one (2l)
White solid; yield 72%;
mp 211–213 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 11.56 (br s, 1H), 8.20 (dd, 1H, J = 1.24,
1.28 Hz), 8.05–8.02 (m, 1H), 7.91 (s, 1H), 7.36–7.31
(m, 1H), 1.23 (s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 209.7, 174.1, 141.3, 137.3, 136.2, 128.3,
125.9, 125.4, 123.4, 111.9, 44.4, 26.6; IR (KBr) νmax (cm–1): 3446, 1611, 1544, 1438, 1333, 1300, 1071,
1001, 868, 748, 543; HRMS (ESI-TOF+) m/z: calcd for C14H15BrNO2+ [(M + H)+], 308.0281; found, 308.0281.

8-Methyl-3-pivaloylquinolin-4(1H)-one (2m)
White solid; yield 68%; mp 231–233 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 11.57 (br s, 1H), 8.05 (d, 1H, J = 8.08 Hz),
7.09 (d, 1H, J = 4.32 Hz), 7.55 (d, 1H, J = 7.04 Hz), 7.29 (t, 1H, J = 7.72 Hz), 2.50 (s,
1H), 1.24 (s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 210.2, 174.7, 140.6, 138.3, 133.4, 127.1,
127.1, 124.2, 123.8, 123.0, 44.3, 26.7, 17.5; IR (KBr) νmax (cm–1): 3448, 1621, 1552, 1445, 1363,
1280, 1070, 1003, 886, 545; HRMS (ESI-TOF+) m/z: calcd for C15H18NO2+ [(M + H)+], 224.1332; found, 224.1329.

8-Methoxy-3-pivaloylquinolin-4(1H)-one (2n)
White solid; yield 64%; mp 227–230 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 11.84 (br d, 1H, J = 5.64 Hz), 7.83 (d, 1H, J = 6.44 Hz), 7.73 (dd, 1H, J = 1.80, 1.80
Hz), 7.34–7.27 (m, 2H), 4.00 (s, 3H), 1.23 (s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm): δ
210.2, 174.2, 149.0, 140.1, 130.3, 127.8, 124.4, 123.3, 117.0, 112.1,
56.7, 44.3, 26.6; IR (KBr) νmax (cm–1): 3445, 2960, 2338, 1668, 1549, 1454, 1304, 1270, 1080, 862, 773,
673; HRMS (ESI-TOF+) m/z: calcd for C15H18NO3+ [(M + H)+], 260.1281; found, 260.1278.

7-Methyl-3-pivaloylquinolin-4(1H)-one (2o)
White solid; yield 50%;
mp 246–248 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.08 (br s, 1H), 8.07 (dd, 2H, J = 8.24,
5.64 Hz), 7.36 (s, 1H), 7.22 (dd, 1H, J = 1.16, 1.12
Hz), 2.43 (s, 3H), 1.25 (s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 210.3, 174.3, 142.9, 140.5,
139.9, 126.1, 125.8, 124.9, 123.0, 118.7, 44.2, 27.0, 26.7; IR (KBr)
νmax (cm–1): 3445, 3228, 3095,
2874, 1692, 1630, 1558, 1524, 1475, 1363, 1307, 1070, 999, 889, 775,
698, 560; HRMS (ESI-TOF+) m/z: calcd for C15H18NO2+ [(M + H)+], 224.1332; found, 224.1330.

7-Methoxy-3-pivaloylquinolin-4(1H)-one (2p)
White solid; yield 40%;
mp 245–246 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.00 (br d, 1H, J = 5.64 Hz), 8.07 (d, 1H, J = 9.60 Hz), 7.97 (d, 1H, J = 6.24 Hz),
7.00–6.97 (m, 2H), 3.86 (s, 3H), 1.23 (s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm): δ
210.4, 174.0, 162.6, 141.5, 140.4, 127.7, 123.0, 121.0, 114.4, 99.9,
55.9, 44.3, 26.7; IR (KBr) νmax (cm–1): 3445, 2979, 1633, 1528, 1478, 1355, 1268, 1096, 1021, 568; HRMS
(ESI-TOF+) m/z: calcd
for C15H18NO3+ [(M + H)+], 260.1281; found, 260.1279.

6-Benzyl-3-pivaloylquinolin-4(1H)-one (2q)
White solid; yield 57%;
mp 239–240 °C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.17 (br s, 1H), 8.00 (d, 2H, J = 2.16 Hz),
7.59–7.52 (m, 2H), 7.32–7.17 (m, 5H), 4.07 (s, 2H),
1.23 (s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 210.3, 174.3, 141.4, 140.4, 138.1, 137.8,
133.5, 129.2, 128.9, 126.9, 126.5, 125.0, 122.9, 119.1, 41.1, 26.7;
IR (KBr) νmax (cm–1): 3488, 2970,
1689, 1620, 1551, 1488, 1413, 1358, 1202, 1073, 1010, 839, 791, 616;
HRMS (ESI-TOF+) m/z:
calcd for C21H22NO2+ [(M
+ H)+], 320.1645; found, 320.1640.

3-Pivaloylbenzo[g]quinolin-4(1H)-one (2r)
White solid; yield 51%; mp 222–224
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.40 (br s, 1H), 10.24 (d, 1H, J = 8.44 Hz), 8.17 (d, 1H, J = 8.88 Hz), 7.99 (t,
2H, J = 7.96 Hz), 7.72–7.59 (m, 3H), 1.27
(s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 211.9, 177.0, 140.8, 135.3, 134.1, 131.3,
130.2, 128.7, 128.6, 128.1, 126.7, 126.3, 118.8, 118.6, 44.5, 27.0;
IR (KBr) νmax (cm–1): 3445, 1688,
1634, 1600, 1492, 1357, 1260, 1204, 1069, 865, 825, 574; HRMS (ESI-TOF+) m/z: calcd for C18H18NO2+ [(M + H)+], 280.1332;
found, 280.1331.

3-Pivaloylbenzo[h]quinolin-4(1H)-one (2s)
White solid; yield 74%;
mp 247–249
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.55 (br d, 1H, J = 4.80 Hz), 8.70
(t, 1H, J = 3.24 Hz), 8.19–8.00 (m, 3H), 7.84–7.77
(m, 3H), 1.27 (s, 9H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 210.4, 174.2, 138.8, 136.9, 134.8, 129.2,
129.2, 127.5, 125.4, 124.8, 123.8, 122.5, 122.1, 44.4, 26.7; IR (KBr)
νmax (cm–1): 3444, 1664, 1634,
1548, 1425, 1425, 1386, 1272, 1076, 1006, 861, 829, 829, 570; HRMS
(ESI-TOF+) m/z: calcd
for C18H18NO2+ [(M + H)+], 280.1332; found, 280.1331.

3-(Cyclopropanecarbonyl)quinolin-4(1H)-one
(3a)
Brown solid; yield 75%; mp 276–278
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.49 (br s, 1H), 8.46 (s, 1H), 8.26 (dd, 1H, J = 1.28, 1.28 Hz), 7.74–7.70 (m, 1H), 7.63 (d, 1H, J = 8.00 Hz), 7.46–7.42 (m, 1H), 3.69–3.63
(m, 1H), 1.00–0.91 (m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.6, 175.9, 144.4, 139.4,
132.9, 128.4, 126.2, 125.3, 119.3, 118.1, 19.4, 11.7; IR (KBr) νmax (cm–1): 3441, 1646, 1559, 1523, 1474,
1441, 1354, 1274, 1067, 1009, 910, 850, 772, 586; HRMS (ESI-TOF+) m/z: calcd for C13H12NO2+ [(M + H)+], 214.0863;
found, 214.0865.

3-(Cyclopropanecarbonyl)quinolin-4(1H)-one
(3b)
Gray-white solid; yield 76%; mp 275–277
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.61 (br s, 1H), 8.47 (s, 1H), 7.88 (dd, 1H, J = 2.92, 2.92 Hz), 7.72–7.59 (m, 2H), 3.65–3.59
(m, 1H), 1.00–0.97 (m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.4, 175.0, 174.9, 160.9,
158.5, 144.4, 136.1, 130.0, 129.9, 122.2, 121.7, 121.4, 117.3, 110.7,
110.5, 19.4, 11.8; IR (KBr) νmax (cm–1): 3445, 1652, 1572, 1520, 1384, 1362, 1293, 1270, 1091, 1016, 866,
822, 772, 577; HRMS (ESI-TOF+) m/z: calcd for C13H11FNO2+ [(M + H)+], 232.0768; found, 232.0763.

6-Chloro-3-(cyclopropanecarbonyl)quinolin-4(1H)-one
(3c)
White solid; yield 74%; mp >300
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.63 (br s, 1H), 8.48 (s, 1H), 8.15 (d, 1H, J = 2.40 Hz), 7.77–7.65 (m, 2H), 3.62–3.56
(m, 1H), 1.00–0.97 (m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.3, 174.6, 144.7, 138.1,
113.0, 130.0, 129.6, 125.2, 121.7, 118.2, 19.5, 11.9; IR (KBr) νmax (cm–1): 3445, 2338, 1649, 1552, 1399,
1350, 1299, 1076, 1014, 845, 637, 557; HRMS (ESI-TOF+) m/z: calcd for C13H11ClNO2+ [(M + H)+], 248.0473; found,
248.0467.

6-Bromo-3-(cyclopropanecarbonyl)quinolin-4(1H)-one (3d)
White solid; yield 70%;
mp 258–260
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.56 (br s, 1H), 8.43 (s, 1H), 8.24 (d, 1H, J = 2.32 Hz), 7.81 (dd, 1H, J = 2.36, 2.32
Hz), 7.54 (d, 1H, J = 8.76 Hz), 3.56–3.50
(m, 1H), 0.96–0.86 (m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.3, 174.5, 144.7, 138.4,
135.6, 129.9, 128.4, 121.9, 118.3, 118.1, 19.2, 11.9; IR (KBr) νmax (cm–1): 3445, 2338, 1648, 1616, 1551,
1464, 1400, 1364, 1298, 1068, 1014, 920, 841, 585; HRMS (ESI-TOF+) m/z: calcd for C13H11BrNO2+ [(M + H)+],
291.9968; found, 291.9966.

3-(Cyclopropanecarbonyl)-6-iodoquinolin-4(1H)-one (3e)
White solid; yield 71%;
mp >300
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.58 (br s, 1H), 8.51 (d, 1H, J = 1.96 Hz), 8.47 (s, 1H), 8.01 (dd, 1H, J = 2.04,
2.04 Hz), 7.45 (d, 1H, J = 8.64 Hz), 3.61–3.55
(m, 1H), 1.00–0.96 (m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.3, 174.4, 144.7, 141.0,
138.8, 134.7, 130.1, 121.7, 118.4, 90.3, 19.5, 11.9; IR (KBr) νmax (cm–1): 3446, 2329, 1646, 1616, 1550,
1460, 1401, 1343, 1299, 1080, 1014, 550; HRMS (ESI-TOF+) m/z: calcd for C13H11INO2+ [(M + H)+],
339.9829; found, 339.9822.

3-(Cyclopropanecarbonyl)-6-nitroquinolin-4(1H)-one (3f)
Gray-white solid; yield
82%; mp
>300 °C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.90 (br s, 1H), 8.91 (d, 1H, J = 2.64 Hz), 8.52 (s, 1H), 8.47 (dd, 1H, J = 2.68,
2.68 Hz), 7.81 (d, 1H, J = 9.08 Hz), 3.54–3.48
(m, 1H), 1.03–0.98 (m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.1, 175.1, 145.7, 144.2,
143.3, 127.8, 127.1, 122.4, 121.2, 119.1, 19.7, 12.1; IR (KBr) νmax (cm–1): 3445, 1648, 1556, 1505, 1401,
1342, 1301, 1068, 931, 859, 794, 545; HRMS (ESI-TOF+) m/z: calcd for C13H11N2O4+ [(M + H)+], 259.0713;
found, 259.0713.

3-(Cyclopropanecarbonyl)-6-(trifluoromethyl)quinolin-4(1H)-one (3g)
White solid; yield 80%;
mp >300 °C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.77 (br s, 1H), 8.54 (s, 1H), 8.47
(s, 1H), 8.03 (dd, 1H, J = 1.60, 1.84 Hz), 7.83 (d,
1H, J = 8.64 Hz), 3.59–3.53 (m, 1H), 1.00–0.94
(m, 4H); 13C NMR (100 MHz, DOMSO-d6, ppm): δ 199.3, 175.1, 145.5, 141.8, 129.0, 127.9,
125.8, 125.6, 125.2, 123.7, 123.1, 121.0, 119.0, 19.6, 12.0; IR (KBr)
νmax (cm–1): 3445, 1650, 1561,
1525, 1407, 1332, 1297, 1070, 1013, 546; HRMS (ESI-TOF+) m/z: calcd for C14H11F3NO2+ [(M + H)+], 282.0736; found, 282.0731.

6-Acetyl-3-(cyclopropanecarbonyl)quinolin-4(1H)-one (3h)
Brown solid; yield 76%;
mp >300
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.70 (br s, 1H), 8.79 (d, 1H, J = 2.00 Hz), 8.50 (s, 1H), 8.23 (dd, 1H, J = 2.04,
2.08 Hz), 7.72 (d, 1H, J = 8.60 Hz), 3.62–3.56
(m, 1H), 2.66 (s, 3H), 1.02–0.99 (m, 4H); 13C NMR
(100 MHz, DMSO-d6, ppm): δ 199.4,
197.2, 175.8, 145.1, 142.4, 133.3, 131.7, 127.7, 127.5, 119.9, 119.0,
27.1, 19.6, 11.9; IR (KBr) νmax (cm–1): 3446, 3071, 1684, 1649, 1557, 1526, 1481, 1391, 1356, 1297, 1046,
1018, 980, 916, 829, 781, 608, 515; HRMS (ESI-TOF+) m/z: calcd for C15H14NO3+ [(M + H)+], 256.0968; found,
256.0963.

3-(Cyclopropanecarbonyl)-6-methylquinolin-4(1H)-one (3i)
Gray-white solid; yield
65%; mp
277–279 °C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.43 (br d, 1H, J =
5.66 Hz), 8.43 (d, 1H, J = 6.76 Hz), 8.03 (s, 1H),
7.55–7.51 (m, 2H), 3.70–3.64 (m, 1H), 3.34 (s, 3H),
0.99–0.90 (m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.6, 175.7, 143.9, 137.4,
134.8, 134.2, 128.4, 125.6, 119.2, 117.8, 21.2, 19.3, 11.7; IR (KBr)
νmax (cm–1): 3437, 2360, 1651,
1556, 1523, 1489, 1359, 1259, 1194, 1049, 1015, 580; HRMS (ESI-TOF+) m/z: calcd for C14H14NO2+ [(M + H)+], 228.1019;
found, 228.1017.

3-(Cyclopropanecarbonyl)-6-ethylquinolin-4(1H)-one (3j)
White solid; yield 69%;
mp 162–164
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.44 (br s, 1H), 8.43 (d, 1H, J = 5.32 Hz), 8.06 (d, 1H, J = 1.24 Hz), 7.60–7.54
(m, 2H), 3.70–3.64 (m, 1H), 3.33 (s, 1H), 2.76–2.71
(m, 2H), 1.23 (t, 3H, J = 7.56 Hz), 1.00–0.90
(m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.6, 175.8, 143.9, 141.1, 137.6, 133.2,
128.4, 124.3, 119.3, 117.8, 28.3, 19.3, 15.9, 11.7; IR (KBr) νmax (cm–1): 3447, 1651, 1555, 1524, 1490,
1358, 1292, 1213, 1065, 1014, 828, 783, 595; HRMS (ESI-TOF+) m/z: calcd for C15H16NO2+ [(M + H)+], 242.1176;
found, 242.1174.

6-(tert-Butyl)-3-(cyclopropanecarbonyl)quinolin-4(1H)-one (3k)
White solid; yield 54%;
mp 239–241 °C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.44 (br s, 1H), 8.43 (s,
1H), 8.23 (d, 1H, J = 2.96 Hz), 7.83 (dd, 1H, J = 2.28, 2.28 Hz), 7.59 (d, 1H, J = 8.64
Hz), 3.70–3.64 (m, 1H), 1.34 (s, 9H), 1.00–0.90 (m,
4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.6, 175.9, 147.9, 143.9, 137.4, 131.0, 127.9,
121.4, 119.1, 117.9, 35.0, 31.4, 19.4, 11.6; IR (KBr) νmax (cm–1): 3445, 3205, 3078, 2961, 2361,
1655, 1565, 1522, 1388, 1358, 1265, 1088, 1043, 1012, 924, 831, 598,
571; HRMS (ESI-TOF+) m/z: calcd for C17H20NO2+ [(M + H)+], 270.1489; found, 270.1489.

3-(Cyclopropanecarbonyl)-6-methoxyquinolin-4(1H)-one (3l)
White solid; yield 62%;
mp 254–256
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.47 (br d, 1H, J = 5.64 Hz), 8.41
(d, 1H, J = 6.80 Hz), 7.66 (dd, 2H, J = 2.88, 8.96 Hz), 7.38–7.32 (m, 1H), 3.85 (s, 3H), 3.72–3.66
(m, 1H), 0.99–0.90 (m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.6, 175.2, 157.1, 143.1,
133.8, 129.7, 122.7, 121.0, 117.1, 106.2, 55.9, 19.3, 11.6; IR (KBr)
νmax (cm–1): 3445, 2326, 1651,
1584, 1532, 1491, 1384, 1303, 1071, 1013, 817, 567; HRMS (ESI-TOF+) m/z: calcd for C14H14NO3+ [(M + H)+], 244.0968;
found, 244.0965.

8-Bromo-3-(cyclopropanecarbonyl)quinolin-4(1H)-one (3m)
White solid; yield 78%;
mp 261–263
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 11.80 (br s, 1H), 8.38 (s, 1H), 8.27 (dd, 1H, J = 1.36, 1.32 Hz), 8.07 (dd, 1H, J = 1.32,
1.32 Hz), 7.38 (t, 1H, J = 7.84 Hz), 3.62–3.56
(m, 1H), 1.02–0.94 (m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.2, 175.3, 145.1, 137.1,
136.5, 130.1, 126.2, 126.2, 118.3, 112.3, 19.5, 12.0; IR (KBr) νmax (cm–1): 3447, 1657, 1601, 1543, 1436,
1389, 1328, 1273, 1206, 1068, 1008, 907, 788, 756, 545; HRMS (ESI-TOF+) m/z: calcd for C13H11BrNO2+ [(M + H)+],
291.9968; found, 291.9965.

3-(Cyclopropanecarbonyl)-8-methylquinolin-4(1H)-one (3n)
White solid; yield 64%;
mp 242–244
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 11.80 (br d, 1H, J = 5.64 Hz), 8.34
(d, 1H, J = 6.96 Hz), 8.12 (d, 1H, J = 7.80 Hz), 7.58–7.56 (m, 1H), 7.33 (t, 1H, J = 7.64 Hz), 3.71–3.64 (m, 1H), 2.51 (s, 3H), 1.01–0.92
(m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.5, 176.1, 144.0, 137.9, 133.8, 128.6,
127.5, 124.9, 124.2, 117.8, 19.4, 17.3, 11.8; IR (KBr) νmax (cm–1): 3446, 2324, 1652, 1553, 1453,
1388, 1282, 1213, 1052, 905, 766, 558; HRMS (ESI-TOF+) m/z: calcd for C14H14NO2+ [(M + H)+], 228.1019; found,
228.1016.

3-(Cyclopropanecarbonyl)-8-isopropylquinolin-4(1H)-one (3o)
White solid; yield 52%;
mp 235–237
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 11.81 (br s, 1H), 8.35 (d, 1H, J = 5.28 Hz), 8.16 (dd, 1H, J = 1.20, 1.20 Hz), 7.66
(dd, 1H, J = 0.96, 1.00 Hz), 7.40 (t, 1H, J = 7.67 Hz), 3.71–3.65 (m, 1H), 3.48–3.42
(m, 1H), 1.29 (d, 6H, J = 6.76 Hz), 1.01–0.92
(m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.5, 176.1, 144.1, 137.7, 136.5, 129.1,
128.9, 125.2, 124.1, 117.5, 26.8, 23.3, 19.4, 11.8; IR (KBr) νmax (cm–1): 3444, 1659, 1611, 1547, 1447,
1390, 1357, 1269, 1208, 1045, 1014, 905, 853, 760, 583; HRMS (ESI-TOF+) m/z: calcd for C16H18NO2+ [(M + H)+], 256.1332;
found, 256.1324.

3-(Cyclopropanecarbonyl)-8-methoxyquinolin-4(1H)-one (3p)
White solid; yield 58%;
mp 245–247
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.07 (br s, 1H), 8.28 (s, 1H), 7.80 (dd, 1H, J = 1.44, 1.48 Hz), 7.38–7.31 (m, 2H), 4.00 (s, 3H),
3.70–3.63 (m, 1H), 1.00–0.91 (m, 4H); 13C
NMR (100 MHz, DMSO-d6, ppm): δ 199.6,
175.7, 149.2, 143.5, 129.8, 129.4, 125.2, 118.2, 117.4, 112.8, 56.8,
19.4, 11.8; IR (KBr) νmax (cm–1): 3444, 3190, 1654, 1573, 1533, 1466, 1392, 1287, 1264, 1219, 1077,
1008, 932, 806, 755, 587, 529; HRMS (ESI-TOF+) m/z: calcd for C14H14NO3+ [(M + H)+], 244.0968; found,
244.0966.

7-Bromo-3-(cyclopropanecarbonyl)quinolin-4(1H)-one (3q)
White solid; yield 67%;
mp 289–291
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.41 (br s, 1H), 8.42 (s, 1H), 8.08 (d, 1H, J = 8.64 Hz), 7.76 (d, 1H, J = 1.76 Hz),
7.53 (dd, 1H, J = 1.84, 1.80 Hz), 3.55–3.49
(m, 1H), 0.94–0.86 (m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.4, 175.3, 145.0, 140.4,
128.5, 128.3, 127.3, 126.3, 121.6, 118.6, 19.4, 11.9; IR (KBr) νmax (cm–1): 3448, 1650, 1524, 1457, 1393,
1295, 1077, 1013, 778, 548; HRMS (ESI-TOF+) m/z: calcd for C13H11BrNO2+ [(M + H)+], 293.9947; found, 293.9941.

3-(Cyclopropanecarbonyl)-7-methylquinolin-4(1H)-one
(3r)
Pale-yellow solid; yield 44%; mp
261–263 °C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.37 (br s, 1H), 8.41 (s, 1H), 8.13
(d, 1H, J = 8.24 Hz), 7.38 (s, 1H), 7.27 (dd, 1H, J = 1.08, 1.08 Hz), 3.70–3.63 (m, 1H), 2.43 (s, 3H),
0.99–0.90 (m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.6, 175.7, 144.2, 143.3,
139.5, 126.9, 126.3, 126.2, 118.6, 118.0, 21.6, 19.4, 11.7; IR (KBr)
νmax (cm–1): 3445, 1648, 1559,
1528, 1477, 1385, 1355, 1284, 1226, 1046, 1011, 909, 849, 788, 592,
513; HRMS (ESI-TOF+) m/z: calcd for C14H14NO2+ [(M + H)+], 228.1019; found, 228.1015.

3-(Cyclopropanecarbonyl)-7-methoxyquinolin-4(1H)-one (3s)
Pale-brown solid; yield
49%; mp
271–273 °C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.26 (br s, 1H), 8.40 (s, 1H), 8.15
(dd, 1H, J = 1.16, 1.20 Hz), 7.03–7.01 (m,
2H), 3.86 (s, 3H), 3.68–3.63 (m, 1H), 0.99–0.89 (m,
4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.6, 175.4, 162.8, 144.3, 141.2, 128.1, 122.4,
118.0, 114.7, 100.6, 56.0, 19.3, 11.7; IR (KBr) νmax (cm–1): 3442, 1648, 1573, 1532, 1481, 1386, 1267,
1179, 1024, 853, 783, 591, 512; HRMS (ESI-TOF+) m/z: calcd for C14H14NO3+ [(M + H)+], 244.0968; found,
244.0964.

7,8-Dichloro-3-(cyclopropanecarbonyl)quinolin-4(1H)-one (3t)
White solid; yield 67%;
mp >300
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.16 (br s, 1H), 8.34 (d, 1H, J = 3.12 Hz), 8.19 (d, 1H, J = 8.72 Hz), 7.66 (d,
1H, J = 8.76 Hz), 3.58–3.51 (m, 1H), 1.01–0.96
(m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.1, 174.9, 145.3, 137.4, 136.3, 128.3,
126.4, 126.2, 121.0, 118.7, 19.6, 12.2; IR (KBr) νmax (cm–1): 3445, 2390, 1658, 1604, 1520, 1437, 1386,
1295, 1179, 1067, 1037, 1007, 842, 778, 538; HRMS (ESI-TOF+) m/z: calcd for C13H10C12NO2+ [(M + H)+], 282.0080; found, 282.0078.

6-Benzyl-3-(cyclopropanecarbonyl)quinolin-4(1H)-one (3u)
White solid; yield 78%;
mp 228–230
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.49 (br d, 1H, J = 6.12 Hz), 8.44
(d, 1H, J = 6.68 Hz), 8.08 (s, 1H), 7.61–7.55
(m, 2H), 7.32–7.24 (m, 4H), 7.20 (t, 1H, J = 7.04 Hz), 4.08 (s, 2H), 3.68–3.64 (m, 1H), 1.00–0.90
(m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.6, 175.8, 144.0, 141.3, 138.7, 137.8,
133.8, 129.2, 128.9, 128.4, 126.5, 125.5, 119.5, 117.9, 19.4, 11.7;
IR (KBr) νmax (cm–1): 3421, 1645,
1571, 1512, 1488, 1391, 1357, 1292, 1216, 1072, 1015, 959, 853, 796,
619, 562; HRMS (ESI-TOF+) m/z: calcd for C20H18NO2+ [(M + H)+], 304.1332; found, 304.1331.

6-(4-Chlorophenoxy)-3-(cyclopropanecarbonyl)quinolin-4(1H)-one (3v)
Pale-brown solid; yield
73%; mp 286–288 °C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 12.62 (br s, 1H), 8.47 (s,
1H), 7.73–7.65 (m, 2H), 7.53–7.48 (m, 3H), 7.14 (d,
2H, J = 7.63 Hz), 3.61 (s, 1H), 0.97–0.92
(m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 199.8, 175.5, 142.9, 136.5, 135.0, 129.3,
129.2, 127.7, 125.7, 125.5, 123.8, 122.4, 122.3, 119.9, 19.6, 12.0;
IR (KBr) νmax (cm–1): 3447, 2025,
1652, 1563, 1478, 1390, 1273, 1238, 1086, 1013, 830, 569; HRMS (ESI-TOF+) m/z: calcd for C19H15ClNO3+ [(M + H)+],
340.0735; found, 340.0734.

3-(Cyclopropanecarbonyl)benzo[h]quinolin-4(1H)-one (3w)
Pale-brown solid; yield
69%; mp >300 °C; 1H NMR (400 MHz, F3CCOOD,
ppm): δ 9.41 (s, 1H), 8.57 (d, 1H, J = 8.20
Hz), 8.26 (d, 1H, J = 9.04 Hz), 8.02 (t, 2H, J = 9.84 Hz), 7.87–7.78 (m, 2H), 2.67–2.68
(m, 1H), 1.48–1.33 (m, 4H); 13C NMR (100 MHz, DMSO-d6, ppm): δ 207.4, 175.3, 145.4, 141.1,
139.0, 134.9, 133.5, 131.9, 124.0, 123.3, 121.5, 120.3, 114.7, 19.4,
16.9; IR (KBr) νmax (cm–1): 3446,
2327, 1656, 1574, 1524, 1435, 1389, 1272, 1072, 1010, 756, 536; HRMS
(ESI-TOF+) m/z: calcd
for C17H14NO2+ [(M + H)+], 264.0109; found, 264.0107.

Ethyl 4-Oxo-1,4-dihydroquinoline-3-carboxylate
(4a)
White solid; yield 69%; mp 279–281
°C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 12.32 (br d, 1H, J = 4.92 Hz), 8.55 (d, 1H, J = 6.64 Hz), 8.16 (dd, 1H, J = 0.88, 0.84
Hz), 7.70–7.68 (m, 1H), 7.62 (d, 1H, J = 8.00
Hz), 7.43–7.39 (m, 1H), 4.23 (q, 2H, J = 7.20
Hz), 1.27 (t, 3H, J = 7.12 Hz); 13C NMR
(100 MHz, DMSO-d6, ppm): δ 173.9,
165.2, 145.3, 139.4, 132.8, 127.7, 126.0, 125.1, 119.2, 110.2, 60.0,
14.7; HRMS (ESI-TOF+) m/z: calcd for C12H12NO3+ [(M + H)+], 218.0812; found, 218.0808.

Ethyl 6-Fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate
(4b)
White solid; yield 76%; mp 217–219
°C; 1H NMR (400 MHz, F3CCOOD, ppm): δ
9.11 (s,
1H), 8.07–8.00 (m, 2H), 7.78–7.73 (m, 1H), 4.51 (q,
2H, J = 7.20 Hz), 1.33 (t, 3H, J = 7.16 Hz); 13C NMR (100 MHz, F3CCOOD, ppm):
δ 175.4, 175.3, 169.8, 147.1, 138.7, 130.1, 129.8, 125.4, 125.3,
67.2, 14.5.

Ethyl 6-Chloro-4-oxo-1,4-dihydroquinoline-3-carboxylate
(4c)
Pale-yellow solid; yield 74%; mp >300
°C; 1H NMR (400 MHz, F3CCOOD, ppm): δ
9.15 (s,
1H), 8.45 (d, 1H, J = 1.76 Hz), 8.00–7.96
(m, 2H), 4.54 (q, 2H), 1.36 (t, 3H, J = 7.16 Hz); 13C NMR (100 MHz, F3CCOOD, ppm): δ 174.9,
169.6, 147.4, 140.7, 140.0, 140.0, 126.0, 123.8, 123.2, 107.7, 67.1,
14.4.

Ethyl 6-Bromo-4-oxo-1,4-dihydroquinoline-3-carboxylate (4d)
White solid; yield 72%; mp >300 °C; 1H NMR (400 MHz, F3CCOOD, ppm): δ 9.19 (s,
1H), 8.67 (s, 1H), 8.17 (d, 1H, J = 8.88 Hz), 7.92
(d, 1H, J = 8.84 Hz), 4.56 (t, 2H, J = 4.80 Hz), 1.40 (t, 3H, J = 5.44 Hz); 13C NMR (100 MHz, F3CCOOD, ppm): δ 174.6, 169.4, 147.2,
143.3, 140.1, 129.2, 127.1, 123.4, 123.2, 107.5, 66.9, 14.2.

Ethyl
6-Iodo-4-oxo-1,4-dihydroquinoline-3-carboxylate (4e)
Pale-yellow solid; yield 70%; mp >300 °C; 1H
NMR (400 MHz, F3CCOOD, ppm): δ 9.16 (s,
1H), 8.88 (s, 1H), 8.32 (d, 1H, J = 8.88 Hz), 7.72
(d, 1H, J = 8.92 Hz), 4.55 (q, 2H, J = 7.20 Hz), 1.37 (t, 3H, J = 7.12 Hz); 13C NMR (100 MHz, F3CCOOD, ppm): δ 174.6, 169.6, 149.1,
147.5, 140.8, 136.1, 123.5, 123.1, 107.8, 97.2, 67.1, 14.4.

Ethyl
4-Oxo-6-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxylate
(4f)
White solid; yield 76%; mp >300 °C; 1H NMR (400 MHz, F3CCOOD, ppm): δ 9.24 (s,
1H), 8.76 (s, 1H), 8.20–8.21 (m, 2H), 4.51 (q, 2H, J = 7.20 Hz), 1.32 (t, 3H, J = 7.61 Hz); 13C NMR (100 MHz, F3CCOOD, ppm): δ 176.4,
169.5, 149.3, 143.0, 135.9, 135.5, 135.2, 125.0, 125.0, 123.9, 122.1,
108.3, 67.3, 14.4.

Ethyl 6-Methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate
(4g)
Pale-yellow solid; yield 55%; mp 289–291
°C; 1H NMR (400 MHz, F3CCOOD, ppm): δ
9.08 (s, 1H), 8.31 (s, 1H), 7.93–7.86 (m, 2H), 4.55 (q, 2H, J = 6.40 Hz), 2.54 (s, 3H), 1.40 (t, 3H, J = 5.36 Hz); 13C NMR (100 MHz, F3CCOOD, ppm):
δ 175.1, 169.8, 146.0, 144.7, 142.0, 139.9, 125.7, 122.3, 121.7,
106.8, 66.7, 22.0, 14.3.

Ethyl 6-Ethyl-4-oxo-1,4-dihydroquinoline-3-carboxylate
(4h)
White solid; yield 56%; mp 271–273
°C; 1H NMR (400 MHz, F3CCOOD, ppm): δ
9.04 (s,
1H), 8.29 (s, 1H), 7.93 (dd, 2H, J = 8.76, 8.68 Hz),
4.51 (q, 2H, J = 6.80 Hz), 2.84 (q, 2H, J = 7.60 Hz), 1.36–1.20 (m, 6H); 13C NMR (100 MHz,
F3CCOOD, ppm): δ 175.3, 169.9, 150.9, 146.1, 141.2,
140.1, 124.5, 122.5, 121.9, 106.9, 66.8, 30.5, 15.3, 14.3.

Ethyl
6-Isopropyl-4-oxo-1,4-dihydroquinoline-3-carboxylate (4i)
White solid; yield 64%; mp 247–249 °C; 1H NMR (400 MHz, F3CCOOD, ppm): δ 9.07 (s,
1H), 8.35 (d, 1H, J = 1.52 Hz), 8.02 (dd, 2H, J = 1.80, 1.80 Hz), 7.91 (d, 1H, J = 8.80
Hz), 4.54 (q, 2H, J = 7.20 Hz), 3.14–3.07
(m, 1H), 1.37 (t, 3H, J = 7.16 Hz), 1.27 (d, 6H, J = 6.92 Hz); 13C NMR (100 MHz, F3CCOOD, ppm): δ 175.1, 169.8, 155.3, 145.9, 140.0, 139.9, 106.7,
66.6, 36.4, 23.8, 14.1.

Ethyl 6-(tert-Butyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
(4j)
White solid; yield 71%; mp 271–273
°C; 1H NMR (400 MHz, F3CCOOD, ppm): δ
9.08 (s, 1H), 8.51 (d, 1H, J = 1.92 Hz), 8.23 (dd,
1H, J = 2.04, 2.04 Hz), 7.92 (d, 1H, J = 9.00 Hz), 4.54 (q, 2H, J = 5.36 Hz), 1.39–1.34
(m, 12H); 13C NMR (100 MHz, F3CCOOD, ppm): δ
175.3, 169.8, 157.8, 146.0, 139.8, 139.1, 122.0, 121.9, 121.5, 106.7,
66.6, 37.3, 31.3, 14.2.

Ethyl 6-Methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate
(4k)
Brown solid; yield 69%; mp 282–284
°C; 1H NMR (400 MHz, F3CCOOD, ppm): δ
8.94 (s,
1H), 7.85 (d, 1H, J = 9.28 Hz), 7.70–7.62
(m, 1H), 4.49 (q, 2H, J = 7.20 Hz), 3.87 (s, 3H),
1.34 (t, 3H, J = 7.16 Hz); 13C NMR (100
MHz, F3CCOOD, ppm): δ 174.2, 170.1, 144.4, 137.2,
132.5, 124.3, 123.8, 107.1, 104.7, 66.9, 57.7, 14.5.

Ethyl 8-Methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate
(4l)
Brown solid; yield 70%; mp 255–257
°C; 1H NMR (400 MHz, DMSO-d6, ppm):
δ 11.92 (br s, 1H), 8.34 (s, 1H), 7.72 (dd, 1H, J = 1.24, 1.36 Hz), 7.37–7.31 (m, 2H), 4.24 (q, 2H, J = 7.20 Hz), 4.00 (s, 1H), 1.27 (t, 3H, J = 7.08 Hz); 13C NMR (100 MHz, F3CCOOD, ppm):
δ 173.6, 165.1, 149.1, 144.4, 129.8, 128.6, 125.0, 117.2, 112.6,
110.4, 60.0, 56.8, 14.7.

Ethyl 7-Bromo-4-oxo-1,4-dihydroquinoline-3-carboxylate
(4m)
Pale-pink solid; yield 62%; mp >300
°C; 1H NMR (400 MHz, F3CCOOD, ppm): δ
9.12 (s,
1H), 8.33 (d, 1H, J = 8.80 Hz), 8.18 (s, 1H), 7.91
(d, 1H, J = 8.80 Hz), 4.52 (q, 2H, J = 7.20 Hz), 1.37 (t, 3H, J = 7.20 Hz); 13C NMR (100 MHz, F3CCOOD, ppm): δ 175.8, 169.6, 148.0,
142.0, 136.4, 136.3, 127.9, 125.0, 120.9, 107.4, 67.0, 14.3.

Ethyl
7-Nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate (4n)
Yellow solid; yield 66%; mp >300 °C; 1H NMR
(400 MHz, F3CCOOD, ppm): δ 9.45 (s,
1H), 9.03 (s, 1H), 8.81 (d, 1H, J = 9.20 Hz), 8.62
(t, 1H, J = 1.60 Hz), 4.64 (q, 2H, J = 7.20 Hz), 1.46 (q, 3H, J = 3.20 Hz); 13C NMR (100 MHz, F3CCOOD, ppm): δ 175.7, 169.8, 151.4,
145.9, 132.9, 132.8, 123.1, 117.6, 107.5, 66.9, 58.2, 14.3.

Ethyl
7-Methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate (4o)
Pale-brown solid; yield 50%; mp 281–282
°C; 1H NMR (400 MHz, F3CCOOD, ppm): δ
8.98 (s, 1H), 8.30 (d, 1H, J = 8.48 Hz), 7.80–7.48
(m, 2H), 4.44 (q, 2H, J = 6.40 Hz), 2.46 (s, 3H),
1.27 (t, 3H, J = 6.96 Hz); 13C NMR (100
MHz, F3CCOOD, ppm): δ 175.5, 170.1, 154.3, 147.1,
142.2, 134.6, 126.9, 121.4, 121.1, 120.3, 106.9, 67.1, 66.9, 23.2,
14.6.

Ethyl 7-Methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate (4p)
White solid; yield 41%; mp 290–292 °C; 1H NMR (400 MHz, F3CCOOD, ppm): δ 8.93 (s,
1H), 8.28 (d, 1H, J = 9.24 Hz), 7.28 (t, 2H, J = 9.12 Hz), 4.43 (q, 2H, J = 6.80 Hz),
3.84 (s, 3H), 1.28 (t, 3H, J = 6.88 Hz); 13C NMR (100 MHz, F3CCOOD, ppm): δ 174.4, 170.4, 170.1,
147.0, 144.9, 128.8, 124.4, 116.5, 106.3, 101.7, 66.7, 57.9, 14.5.

Ethyl 6,7-Dichloro-4-oxo-1,4-dihydroquinoline-3-carboxylate
(4q)
Pale-yellow solid; yield 76%; mp >300
°C; 1H NMR (400 MHz, F3CCOOD, ppm): δ
9.17 (s,
1H), 8.56 (s, 1H), 8.17 (s, 1H), 4.53 (d, 2H, J =
7.20 Hz), 1.39 (d, 3H, J = 6.88 Hz); 13C NMR (100 MHz, F3CCOOD, ppm): δ 174.9, 169.6, 148.3,
146.9, 140.6, 140.2, 139.2, 127.8, 123.8, 121.5, 121.4, 107.8, 67.3,
14.4.

Ethyl 6,7-Dimethyl-4-oxo-1,4-dihydroquinoline-3-carboxylate
(4r)
Pale-yellow solid; yield 63%; mp 199–201
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 11.21 (br d, 1H, J = 6.44 Hz), 8.27
(d, 1H, J = 6.88 Hz), 7.36 (d, 1H, J = 7.52 Hz), 7.00 (d, 1H, J = 7.48 Hz), 4.21 (q,
2H, J = 6.80 Hz), 2.74 (s, 3H), 2.41 (s, 3H), 1.27
(t, 3H, J = 7.08 Hz); 13C NMR (100 MHz,
F3CCOOD, ppm): δ 176.7, 165.3, 143.7, 139.2, 138.0,
132.8, 127.3, 126.0, 124.7, 111.7, 59.9, 23.8, 17.5, 14.7.

Ethyl
6-Benzyl-4-oxo-1,4-dihydroquinoline-3-carboxylate (4s)
White solid; yield 79%; mp 264–265 °C; 1H NMR (400 MHz, F3CCOOD, ppm): δ 9.09 (s,
1H), 8.31 (s, 1H), 7.89 (s, 1H), 7.16 (d, 5H, J =
32.80 Hz), 4.52 (d, 2H, J = 2.60 Hz), 4.13 (d, 2H, J = 33.2 Hz), 1.38 (s, 3H); 13C NMR (100 MHz,
F3CCOOD, ppm): δ 175.3, 169.8, 148.0, 146.4, 141.6,
140.4, 140.3, 130.8, 130.8, 128.9, 125.7, 122.4, 122.1, 107.0, 66.8,
43.3, 14.3.

Ethyl 6-(4-Chlorophenoxy)-4-oxo-1,4-dihydroquinoline-3-carboxylate
(4t)
White solid; yield 81%; mp 289–290
°C; 1H NMR (400 MHz, F3CCOOD, ppm): δ
8.66 (s, 1H), 7.61–7.25 (m, 3H), 6.89–6.57 (m, 4H),
4.12 (d, 2H, J = 4.40 Hz), 0.97 (s, 3H); 13C NMR (100 MHz, F3CCOOD, ppm): δ 175.2, 170.5, 155.9,
146.2, 138.3, 134.4, 133.3, 132.7, 125.2, 124.7, 67.6, 15.2; IR (KBr)
νmax (cm–1): 3452, 1692, 1619,
1559, 1478, 1381, 1298, 1237, 800, 746, 609, 547; HRMS (ESI-TOF+) m/z: calcd for C12H11NO3+ [(M + H)+], 344.0684;
found, 344.0677.

Ethyl 4-Oxo-1,4-dihydrobenzo[h]quinoline-3-carboxylate
(4w)
Pale-brown solid; yield 68%; mp 267–270
°C; 1H NMR (400 MHz, F3CCOOD, ppm): δ
8.83 (s, 1H), 8.20 (d, 1H, J = 8.24 Hz), 7.92 (d,
1H, J = 9.12 Hz), 7.73 (q, 2H, J = 5.36 Hz), 7.53–7.45 (m, 2H), 4.21 (q, 2H, J = 7.20 Hz), 1.02 (t, 3H, J = 7.16 Hz); 13C NMR (100 MHz, F3CCOOD, ppm): δ 174.2, 169.5, 144.9,
141.3, 138.7, 134.8, 133.6, 131.8, 131.8, 123.8, 123.0, 120.6, 108.8,
66.9, 14.2, 14.1.

General Procedure for the Synthesis of Quinolones
B
Dicarbonyl compound (1.0 mmol), triethyl orthoformate (1.20
mmol),
and amine (1.0 mmol) were placed inside a 10 mL high-pressure reaction
tube, and then, the tube was closed. The mixture was stirred at 130
°C, and the reaction was monitored by TLC. When the reaction
completed as indicated by TLC, the reaction mixture was filtered to
give the crude product, which was further washed by PE, MeOH, and
EtOAc to give pure quinolones B. The products were further
identified by FTIR, NMR, and HRMS and were in good agreement with
the assigned structures.

Ethyl 4-Oxo-1-phenyl-1,4-dihydroquinoline-3-carboxylate
(5a)
Pale-pink solid; yield 84%; mp 208–209
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 8.46 (s, 1H), 8.30 (d, 1H, J = 7.72
Hz), 7.68 (s, 5H), 7.49 (t, 1H, J = 7.20 Hz), 7.39
(s, 1H), 6.98 (d, 1H, J = 8.40 Hz), 4.21 (t, 2H, J = 6.80 Hz), 1.28–1.18 (m, 3H); 13C NMR
(100 MHz, DMSO-d6, ppm): δ 173.4,
164.6, 148.9, 140.8, 133.2, 130.8, 130.4, 128.1, 127.9, 126.6, 125.9,
118.4, 110.9, 60.3, 14.7; IR (KBr) νmax (cm–1): 3434, 3065, 1718, 1625, 1550, 1510, 1477, 1413, 1364, 1315, 1252,
1223, 1095, 1022, 862, 771, 862, 821, 771, 645, 549; HRMS (ESI-TOF+) m/z: calcd for C18H16NO3+ [(M + H)+], 294.1125;
found, 294.1122.

Ethyl 1-(4-Fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
(5b)
White solid; yield 92%; mp 179–199
°C; 1H NMR (400 MHz, CDCl3, ppm): δ
8.54 (d, 1H, J = 7.96 Hz), 8.48 (s, 1H), 7.54 (t,
1H, J = 8.20 Hz), 7.49–7.41 (m, 3H), 7.33
(t, 2H, J = 8.08 Hz), 6.96 (d, 1H, J = 8.44 Hz), 4.42 (q, 2H, J = 7.20 Hz), 1.40 (t,
3H, J = 7.12 Hz); 13C N MR (100 MHz, DMSO-d6, ppm): δ 174.3, 165.5, 164.2, 161.7,
148.6, 140.6, 136.6, 136.6, 132.4, 129.5, 129.4, 128.3, 127.6, 125.3,
117.6, 117.4, 117.3, 111.5, 61.0, 14.4; HRMS (ESI-TOF+) m/z: calcd for C18H14FNO3Na+ [(M + Na)+], 334.0850; found,
334.0850.

Ethyl 1-(4-Nitrophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
(5c)
White solid; yield 90%; mp 171–173
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 8.51 (t, 3H, J = 5.00 Hz), 8.29
(dd, 1H, J = 1.24, 1.24 Hz), 8.02 (d, 2H, J = 8.88 Hz), 7.68–7.64 (m, 1H), 7.50 (t, 1H, J = 7.64 Hz), 7.05 (d, 1H, J = 8.48 Hz),
4.24 (q, 2H, J = 7.20 Hz), 1.26 (t, 3H, J = 7.08 Hz); 13C NMR (100 MHz, DMSO-d6, ppm): δ 173.5, 164.5, 148.4, 148.4, 145.9, 140.3,
133.3, 130.0, 127.8, 126.7, 126.0, 125.8, 118.2, 115.5, 60.4, 14.6;
IR (KBr) νmax (cm–1): 3444, 1724,
1613, 1526, 1476, 1350, 1252, 1216, 1135, 1097, 1020, 877, 767, 542;
HRMS (ESI-TOF+) m/z:
calcd for C18H14N2O5Na+ [(M + Na)+], 361.0795; found, 361.0788.

Ethyl
4-Oxo-1-(4-(trifluoromethyl)phenyl)-1,4-dihydroquinoline-3-carboxylate
(5d)
White solid; yield 93%; mp 204–206
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 8.53 (s, 1H), 8.28 (d, 1H, J = 7.92
Hz), 8.09 (d, 2H, J = 8.28 Hz), 7.97 (d, 2H, J = 8.16 Hz), 7.65 (t, 1H, J = 7.20 Hz),
7.49 (t, 1H, J = 7.36 Hz), 7.01 (d, 1H, J = 8.44 Hz), 4.23 (q, 2H, J = 6.80 Hz), 1.26 (t,
3H, J = 7.08 Hz); 13C NMR (100 MHz, DMSO-d6, ppm): δ 173.5, 164.5, 148.7, 144.1,
140.5, 133.3, 129.5, 127.9, 127.9, 127.8, 126.6, 125.7, 118.3, 111.3,
60.3, 14.6; IR (KBr) νmax (cm–1): 3448, 1725, 1610, 1553, 1478, 1325, 1250, 1130, 1067, 542; HRMS
(ESI-TOF+) m/z: calcd
for C19H15F3NO3+ [(M + H)+], 362.999; found, 362.0993.

Ethyl 4-Oxo-1-(p-tolyl)-1,4-dihydroquinoline-3-carboxylate
(5e)
White solid; yield 74%; mp 199–201
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 8.42 (s, 1H), 8.29 (dd, 1H, J =
1.36, 1.40 Hz), 7.67–7.62 (m, 1H), 7.54–7.46 (m, 1H),
6.98 (d, 2H, J = 8.48 Hz), 4.22 (d, 2H, J = 6.80 Hz), 2.50–2.45 (m, 3H), 1.26 (t, 3H, J = 7.12 Hz); 13C NMR (100 MHz, DMSO-d6, ppm): δ 173.4, 164.6, 148.9, 141.0, 140.1, 138.4,
133.1, 131.2, 128.0, 127.8, 126.6, 125.5, 118.5, 110.9, 60.3, 21.2,
14.7; IR (KBr) νmax (cm–1): 3433,
1724, 1625, 1550, 1473, 1406, 1314, 1243, 1207, 1125, 1090, 853, 769,
548; HRMS (ESI-TOF+) m/z: calcd for C19H18NO3+ [(M + H)+], 308.1281; found, 308.1275.

Ethyl 1-(4-(tert-Butyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
(5f)
White solid; yield 76%; mp 207–209
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 8.45 (s, 1H), 8.29 (d, 1H, J = 7.76
Hz), 7.70–7.47 (m, 6H), 6.99 (d, 1H, J = 8.40
Hz), 4.23 (q, 2H, J = 6.80 Hz), 1.37 (s, 9H), 1.26
(t, 3H, J = 6.96 Hz); 13C NMR (100 MHz,
DMSO-d6, ppm): δ 173.4, 164.5, 152.9,
149.0, 140.9, 138.3, 133.2, 127.9, 127.5, 127.5, 126.6, 125.5, 118.5,
110.8, 60.3, 14.7; IR (KBr) νmax (cm–1): 3446, 1725, 1627, 1513, 1413, 1363, 1249, 1091, 1022, 764, 550;
HRMS (ESI-TOF+) m/z:
calcd for C22H24NO3+ [(M
+ H)+], 350.1751; found, 350.1746.

Ethyl 1-(2-Bromophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
(5g)
White solid; yield 82%; mp 183–185
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 8.48 (s, 1H), 8.30 (d, 1H, J = 7.96
Hz), 8.00 (d, 1H, J = 7.96 Hz), 7.88 (d, 1H, J = 7.72 Hz), 6.77 (d, 1H, J = 8.44 Hz),
7.73–7.61 (m, 3H), 7.50 (t, 3H, J = 7.40 Hz),
4.25 (q, 2H, J = 7.04 Hz), 1.27 (t, 3H, J = 7.08 Hz); 13C NMR (100 MHz, DMSO-d6, ppm): δ 173.5, 164.5, 148.7, 140.2, 139.1, 134.4,
133.5, 132.7, 131.0, 130.3, 127.7, 126.7, 125.7, 122.3, 117.9, 111.7,
60.5, 14.6; IR (KBr) νmax (cm–1): 3440, 1732, 1626, 1478, 1364, 1245, 1092, 810, 763, 543; HRMS
(ESI-TOF+) m/z: calcd
for C18H14BrNO3Na+ [(M
+ Na)+], 396.0029; found, 396.0021.

Ethyl 1-(3-Bromophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
(5h)
White solid; yield 85%; mp 267–269
°C; 1H NMR (400 MHz, F3CCOOD, ppm): δ
9.17 (s, 1H), 8.69 (d, 1H, J = 8.08 Hz), 8.04 (t,
1H, J = 7.00 Hz), 7.92–7.85 (m, 2H), 7.63–7.40
(m, 4H), 4.55 (q, 2H, J = 7.20 Hz), 1.35 (t, 3H, J = 6.68 Hz); 13C NMR (100 MHz, F3COOD, ppm): δ 176.0, 169.5, 151.2, 143.8, 141.8, 140.6, 137.8,
134.1, 132.6, 131.6, 127.9, 126.9, 126.6, 122.9, 67.2, 14.4; IR (KBr)
νmax (cm–1): 3445, 2360, 1720,
1628, 1475, 1412, 1244, 1070, 1011, 767, 545; HRMS (ESI-TOF+) m/z: calcd for C18H14BrNO3Na+ [(M + Na)+], 396.0029; found, 396.0022.

Ethyl 1-(3-Nitrophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
(5i)
White solid; yield 88%; mp 291–293
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 8.63 (t, 1H, J = 2.08 Hz), 8.55
(s, 1H), 8.50–8.47 (m, 1H), 8.31 (dd, 1H, J = 1.36, 1.36 Hz), 8.16–8.14 (m, 1H), 7.95 (t, 1H, J = 8.16 Hz), 7.67–7.63 (m, 1H), 7.52–7.48
(m, 1H), 7.03 (d, 1H, J = 8.36 Hz), 4.23 (q, 2H, J = 6.80 Hz), 1.26 (t, 3H, J = 7.08 Hz); 13C NMR (100 MHz, F3CCOOD, ppm): δ 176.6,
169.6, 151.8, 151.5, 143.9, 142.0, 141.1, 135.4, 134.8, 133.0, 129.3,
128.4, 124.6, 121.5, 107.6, 67.5, 14.6; IR (KBr) νmax (cm–1): 3430, 3059, 1724, 1608, 1530, 1476, 1348,
1312, 1250, 1095, 930, 763, 673, 540; HRMS (ESI-TOF+) m/z: calcd for C18H14N2O5Na+ [(M + Na)+],
361.0795; found, 361.0794.

Ethyl 4-Oxo-1-(m-tolyl)-1,4-dihydroquinoline-3-carboxylate
(5j)
White solid; yield 71%; mp 209–212
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 8.43 (s, 1H), 8.29 (dd, 1H, J =
1.44, 1.44 Hz), 7.68–7.63 (m, 1H), 7.56 (t, 1H, J = 7.48 Hz), 7.50–7.43 (m, 4H), 6.99 (d, 1H, J = 8.44 Hz), 4.24 (q, 2H, J = 6.80 Hz), 2.42 (s,
3H), 1.26 (t, 3H, J = 7.08 Hz); 13C NMR
(100 MHz, DMSO-d6, ppm): δ 173.4,
164.6, 148.8, 140.8, 140.7, 133.1, 131.0, 130.5, 128.4, 127.9, 126.6,
125.5, 125.0, 118.5, 110.9, 60.3, 21.2, 14.7; IR (KBr) νmax (cm–1): 3448, 1725, 1627, 1551, 1480,
1362, 1252, 1090, 763, 543; HRMS (ESI-TOF+) m/z: calcd for C19H17NO3Na+ [(M + Na)+], 330.1101; found, 330.1097.

Ethyl 1-(3-Methoxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
(5k)
White solid; yield 80%; mp 235–237
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 8.46 (s, 1H), 8.29 (d, 1H, J = 7.76
Hz), 7.69–7.47 (m, 3H), 7.31–7.21 (m, 3H), 7.03 (d,
1H, J = 8.36 Hz), 4.25 (q, 2H, J = 6.08 Hz), 3.83 (s, 3H), 1.27 (t, 3H, J = 6.84
Hz); 13C NMR (100 MHz, DMSO-d6, ppm): δ 173.4, 164.6, 161.0, 148.8, 141.8, 140.8, 133.2,
131.5, 127.9, 126.5, 125.5, 119.9, 118.5, 116.4, 113.6, 110.8, 60.3,
56.1, 14.7; IR (KBr) νmax (cm–1): 3442, 1725, 1605, 1477, 1364, 1341, 1266, 1230, 1093, 762, 552;
HRMS (ESI-TOF+) m/z:
calcd for C19H14NO4Na+ [(M + Na)+], 346.1050; found, 346.1046.

Ethyl 1-(3,4-Difluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
(5l)
White solid; yield 83%; mp 234–236
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 8.49 (s, 1H), 8.27 (d, 1H, J = 6.24
Hz), 7.99 (s, 1H), 7.77–7.49 (m, 4H), 7.04 (d, 1H, J = 7.88 Hz), 4.22 (d, 2H, J = 6.80 Hz),
1.26 (t, 3H, J = 6.84 Hz); 13C NMR (100
MHz, DMSO-d6, ppm): δ 173.5, 164.6,
148.9, 140.9, 137.2, 133.2, 127.8, 126.5, 126.0, 125.6, 119.4, 118.8,
118.4, 111.2, 60.3, 14.7; IR (KBr) νmax (cm–1): 3441, 3036, 1724, 1609, 1516, 1478, 1319, 1212, 1093, 1025, 911,
863, 766, 582; HRMS (ESI-TOF+) m/z: calcd for C18H13F2NO3Na+ [(M + Na)+], 352.0756; found, 352.0750.

Ethyl 4-Oxo-1-(pyridin-3-yl)-1,4-dihydroquinoline-3-carboxylate
(5m)
White solid; yield 62%; mp 235–242
°C; 1H NMR (400 MHz, DMSO-d6, ppm): δ 8.86 (t, 2H, J = 6.14 Hz), 8.55
(s, 1H), 8.30 (dd, 2H, J = 7.76, 7.64 Hz), 7.75–7.65
(m, 2H), 7.51 (t, 1H, J = 7.40 Hz), 6.97 (d, 1H, J = 4.36 Hz), 4.24 (q, 2H, J = 6.80 Hz),
1.27 (t, 3H, J = 6.96 Hz); 13C NMR (100
MHz, DMSO-d6, ppm): δ 173.5, 164.6,
151.2, 149.1, 140.9, 137.6, 136.4, 133.3, 127.8, 126.6, 125.7, 125.3,
118.3, 114.4, 60.4, 14.7; IR (KBr) νmax (cm–1): 3449, 1725, 1611, 1478, 1417, 1363, 1251, 1093, 1026, 766, 543;
HRMS (ESI-TOF+) m/z:
calcd for C17H15N2O3+ [(M + H)+], 295.1077; found, 295.1080.

General Procedure for the Synthesis of Sarafloxacin
Dicarbonyl
compound (2.0 mmol), triethyl orthoformate (2.25 mmol),
and amine compound (2.0 mmol) were placed inside a 10 mL high-pressure
reaction tube, and then, the tube was closed. The mixture was stirred
at 130 °C for 24 h, and the reaction was monitored by TLC. Then,
we continue to add piperazine (2.0 mmol) and employ acetonitrile (2.0
mL) as a solvent, which reacted for 4 h. Then, the addition of 50%
NaOH (2.0 mL) promoted the hydrolysis of the ester group. Last, the
mixture was purified by acid/base extraction and washed by PE, MeOH,
and EtOAc to give pure sarafloxacin with up to 82% yield.

Sarafloxacin
(6-Fluoro-1-(4-fluorophenyl)-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic
acid)
Yellow solid; yield 82%; mp >300 °C; 1H NMR (400 MHz, DMSO-d6, ppm): δ
8.64 (s, 1H), 7.98 (d, 1H, J = 13.16 Hz), 7.80 (s,
2H), 7.55 (t, 2H, J = 7.84 Hz), 6.36 (t, 1H, J = 6.60 Hz), 2.96 (s, 4H), 2.79 (s, 4H); 13C
NMR (100 MHz, DMSO-d6, ppm): δ 176.5,
165.6, 163.6, 161.1, 154.1, 151.6, 148.4, 145.6, 145.5, 139.2, 136.1,
129.8, 129.7, 118.2, 118.1, 117.2, 117.0, 111.0, 110.7, 107.2, 106.0;
HRMS (ESI-TOF+) m/z:
calcd for C20H18F2N3O3+ [(M + H)+], 386.1311; found, 386.1313.

Ethyl 6,7-Difluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
White solid; yield 94%; mp >300 °C; 1H NMR (400
MHz, DMSO-d6, ppm): δ 8.45 (s, 1H),
8.07 (t, 1H, J = 8.96 Hz), 7.78 (s, 2H), 7.53 (t,
2H, J = 8.00 Hz), 7.04–6.99 (m, 1H), 4.20
(d, 2H, J = 6.76 Hz), 1.24 (t, 3H, J = 6.64 Hz); 13C NMR (100 MHz, DMSO-d6, ppm): δ 172.0, 164.2, 161.7, 149.7, 138.4, 136.8,
130.5, 130.4, 125.1, 117.9, 117.7, 114.2, 114.0, 110.8, 107.9, 107.9,
60.5, 14.6; HRMS (ESI-TOF+) m/z: calcd for C18H12F3NO3Na+ [(M + Na)+], 370.0661; found, 370.0662.

Supporting Information Available
The Supporting Information
is
available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.8b01378.X-ray crystallography
data (CIF)

Copies of 1H NMR and 13C NMR spectra
(PDF)



Supplementary Material
ao8b01378_si_001.cif

 ao8b01378_si_002.pdf

 The authors
declare no competing financial interest.

Acknowledgments
This work was financially
supported by the National
Natural Science Foundation of China (nos. 21662046 and 21202142).
==== Refs
References
U.S. Environmental Protection
Agency  . http://www.epa.gov (accessed March 1, 2014 ).
Dunn P. J. 
The importance
of green chemistry in process research and development . Chem. Soc. Rev. 
2012 , 41 , 1452 –1461 . 10.1039/c1cs15041c .21562677 
a Sheldon R. A. 
Metrics
of Green Chemistry and Sustainability: Past,
Present, and Future . ACS Sustainable Chem. Eng. 
2018 , 6 , 32 –48 . 10.1021/acssuschemeng.7b03505 . b Erythropel H. C. ; Zimmerman J. B. ; de Winter T. M. ; Petitjean L. ; Melnikov F. ; Lam C. H. ; Lounsbury A. W. ; Mellor K. E. ; Janković N. Z. ; Tu Q. ; Pincus L. N. ; Falinski M. M. ; Shi W. ; Coish P. ; Plata D. L. ; Anastas P. T. 
The Green ChemisTREE: 20 years after
taking root with the 12 principles . Green Chem. 
2018 , 20 , 1929 –1961 . 10.1039/c8gc00482j .
For domino integration strategy, see:

a Tietze L. F. ; Brasche G. ; Gericke K.  Domino Reactions in Organic
Synthesis ; Wiley-VCH : Weinheim , 2006 ; pp 9 –13 .b Nimje R. Y. ; Leskinen M. V. ; Pihko P. M. 
A Three-Component
Palladium-Catalyzed Oxidative CC Coupling Reaction: A Domino Process
in Two Dimensions . Angew. Chem., Int. Ed. 
2013 , 52 , 4818 –4822 . 10.1002/anie.201300833 . c Zeng X. ; Ni Q. ; Raabe G. ; Enders D. 
A Branched Domino Reaction: Asymmetric
Organocatalytic Two-Component Four-Step Synthesis of Polyfunctionalized
Cyclohexene Derivatives . Angew. Chem., Int.
Ed. 
2013 , 52 , 2977 –2980 . 10.1002/anie.201209581 . d Gao M. ; Yang Y. ; Wu Y.-D. ; Deng C. ; Shu W.-M. ; Zhang D.-X. ; Cao L.-P. ; She N.-F. ; Wu A.-X. 
An Efficient Synthesis of Hydantoins via Sustainable Integration
of Coupled Domino Processes . Org. Lett. 
2010 , 12 , 4026 –4029 . 10.1021/ol1015948 .20795705 
a Yan S. ; Chen Y. ; Liu L. ; He N. ; Lin J. 
Three-component solvent-free synthesis of highly substituted bicyclic
pyridines containing a ring-junction nitrogen . Green Chem. 
2010 , 12 , 2043 –2052 . 10.1039/c0gc00373e . b Grossmann A. ; Enders D. 
N-Heterocyclic Carbene Catalyzed
Domino Reactions . Angew. Chem., Int. Ed. 
2012 , 51 , 314 –325 . 10.1002/anie.201105415 .
For atom-economical,
see: Trost B. 
The atom economy--a
search for synthetic efficiency . Science 
1991 , 254 , 1471 –1477 . 10.1126/science.1962206 .1962206 
For step-economical,
see: Wender P. A. ; Verma V. A. ; Paxton T. J. ; Pillow T. H. 
Function-Oriented Synthesis, Step
Economy, and Drug Design . Acc. Chem. Res. 
2008 , 41 , 40 –49 . 10.1021/ar700155p .18159936 
For the discussion of the advantages of one-pot
reactions and domino reactions, see:

a Jiang B. ; Tu S.-J. ; Kaur P. ; Wever W. ; Li G. 
Four-Component Domino
Reaction Leading to Multifunctionalized Quinazolines . J. Am. Chem. Soc. 
2009 , 131 , 11660 –11661 . 10.1021/ja904011s .19722590  b Nicolaou K.
C. ; Edmonds D. J. ; Bulger P. G. 
Cascade Reactions in Total Synthesis . Angew. Chem., Int. Ed. 
2006 , 45 , 7134 –7186 . 10.1002/anie.200601872 . c Hayashi Y. ; Koshino S. ; Ojima K. ; Kwon E. 
Pot Economy in the Total Synthesis of Estradiol Methyl Ether by Using
an Organocatalyst . Angew. Chem., Int. Ed. 
2017 , 56 , 11812 –11815 . 10.1002/anie.201706046 . d Ishikawa H. ; Suzuki T. ; Hayashi Y. 
High-Yielding Synthesis of the Anti-Influenza
Neuramidase Inhibitor (−)-Oseltamivir by Three ″One-Pot″
Operations . Angew. Chem., Int. Ed. 
2009 , 48 , 1304 –1307 . 10.1002/anie.200804883 .
a Anastas P. T. ; Warner J. C.  Green
Chemistry: Theory and Practice ; Oxford University
Press : New York , 2000 ; pp 4 –8 .b Dicks A. P. ; Matlack A. S.  Problem-Solving Exercises
in Green and Sustainable Chemistry ; CRC Press : Boca Raton , 2015 ; pp 24 –30 .
a Eicher T. ; Hauptmann S. ; Speicher A.  The Chemistry of Heterocycles:
Structures, Reactions, Synthesis,
and Applications ; John Wiley & Sons : Hoboken , 2013 ; pp 9 –16 .b Katritzky A. R. ; Pozharskii A. F. ; Soldatenkov A.  Heterocycles in Life
and Society: An Introduction to Heterocyclic Chemistry, Biochemistry
and Applications ; John Wiley & Sons : Hoboken , 2011 ; pp 21 –35 .
a Ma H. ; Guo C. ; Zhan Z. ; Lu G. ; Zhang Y. ; Luo X. ; Cui X. ; Huang G. 
Transition-metal-free
oxidative intermolecular cyclization reaction: synthesis of 2-aryl-4-quinolones . New J. Chem. 
2017 , 41 , 5280 –5283 . 10.1039/c7nj01293d . b Mitscher L. A. 
Bacterial Topoisomerase Inhibitors: Quinolone and Pyridone
Antibacterial Agents . Chem. Rev. 
2005 , 105 , 559 –592 . 10.1021/cr030101q .15700957 
For examples of pharmaceutically active compounds
containing the quinolone scaffold, see:

a Xia Y. ; Yang Z.-Y. ; Xia P. ; Hackl T. ; Hamel E. ; Mauger A. ; Wu J.-H. ; Lee K.-H. 
Antitumor Agents.
211. Fluorinated 2-Phenyl-4-quinolone Derivatives as Antimitotic Antitumor
Agents1 . J. Med. Chem. 
2001 , 44 , 3932 –3936 . 10.1021/jm0101085 .11689079  b Cross R. M. ; Monastyrskyi A. ; Mutka T. S. ; Burrows J. N. ; Kyle D. E. ; Manetsch R. 
Endochin Optimization: Structure–Activity and
Structure–Property Relationship Studies of 3-Substituted 2-Methyl-4(1H)-quinolones with Antimalarial Activity . J. Med. Chem. 
2010 , 53 , 7076 –7094 . 10.1021/jm1007903 .20828199  c Llinàs-Brunet M. ; Bailey M. D. ; Ghiro E. ; Gorys V. ; Halmos T. ; Poirier M. ; Rancourt J. ; Goudreau N. 
A Systematic Approach
to the Optimization of Substrate-Based Inhibitors of the Hepatitis
C Virus NS3 Protease: Discovery of Potent and Specific Tripeptide
Inhibitors . J. Med. Chem. 
2004 , 47 , 6584 –6594 . 10.1021/jm0494523 .15588093  d Meyer E. ; Schwab F. ; Gastmeier P. ; Ruden H. ; Heininger A. 
Antifungal
use in intensive care units . J. Antimicrob.
Chemother. 
2007 , 60 , 619 –624 . 10.1093/jac/dkm255 .17609195  e Mitscher L. A. 
Bacterial Topoisomerase Inhibitors: Quinolone and Pyridone
Antibacterial Agents . Chem. Rev. 
2005 , 105 , 559 –592 . 10.1021/cr030101q .15700957 
a Laurence B. ; Marie-Emmanuelle L. ; Gilles R. ; Francis T.  Novel method of synthesis of fluoroquinolones . U.S. Patent 20,090,054,643 A1 , 2009 .b Chu D. T. W. ; Fernandes P. B. ; Claiborne A. K. ; Pihuleac E. ; Nordeen C. W. ; Maleczka R. E. ; Pernet A. G. 
Synthesis
and structure-activity relationships of novel arylfluoroquinolone
antibacterial agents . J. Med. Chem. 
1985 , 28 , 1558 –1564 . 10.1021/jm00149a003 .3934382 
Baker W. R. ; Cai S. ; Dimitroff M. ; Fang L. ; Huh K. K. ; Ryckman D. R. ; Shang X. ; Shawar R. M. ; Therrien J. H. 
A Prodrug Approach
toward the Development of Water Soluble Fluoroquinolones and Structure–Activity
Relationships of Quinoline-3-carboxylic Acids . J. Med. Chem. 
2004 , 47 , 4693 –4709 . 10.1021/jm0497895 .15341485 
Xiao Y. ; Lu Y. ; Kang Z. ; Zhang M. ; Liu Y. ; Zhang M. ; Li T. 
Pharmacokinetics
of antofloxacin hydrochloride, a new fluoroquinolone
antibiotic, after single oral dose administration in Chinese healthy
male volunteers . Biopharm. Drug Dispos. 
2008 , 29 , 167 –172 . 10.1002/bdd.600 .18240275 
Takei M. ; Fukuda H. ; Kishii R. ; Hosaka M. 
Target Preference of
15 Quinolones against Staphylococcus aureus, Based on Antibacterial
Activities and Target Inhibition . Antimicrob.
Agents Chemother. 
2001 , 45 , 3544 –3547 . 10.1128/aac.45.12.3544-3547.2001 .11709337 
Giannarini G. ; Tascini C. ; Selli C. 
Prulifloxacin:
clinical studies of
a broad-spectrum quinolone agent . Future Microbiol. 
2009 , 4 , 13 –24 . 10.2217/17460913.4.1.13 .19207096 
Candel F. J. ; Peñuelas M. 
Delafloxacin: design, development
and potential place
in therapy . Drug Des. Dev. Ther. 
2017 , 11 , 881 –891 . 10.2147/dddt.s106071 .
Sax P. E. ; DeJesus E. ; Mills A. ; Zolopa A. ; Cohen C. ; Wohl D. ; Gallant J. E. ; Liu H. C. ; Zhong L. ; Yale K. ; White K. ; Kearney B. P. ; Szwarcberg J. ; Quirk E. ; Cheng A. K. 
Co-formulated elvitegravir, cobicistat,
emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine,
and tenofovir for initial treatment of HIV-1 infection: a randomised,
double-blind, phase 3 trial, analysis of results after 48 weeks . Lancet 
2012 , 379 , 2439 –2448 . 10.1016/s0140-6736(12)60917-9 .22748591 
Camps R. 
Synthese von
α- und γ-Oxychinolinen . Arch. Pharmazie 
1899 , 237 , 659 –691 . 10.1002/ardp.18992370902 .
Conrad M. ; Limpach L. 
synthesen von Chinolinderivaten mittelst
Acetessigester . Ber. Dtsch. Chem. Ges. 
1887 , 20 , 944 –948 . 10.1002/cber.188702001215 .
Gould R. G. ; Jacobs W. A. 
The Synthesis of
Certain Substituted Quinolines and
5,6-Benzoquinolines . J. Am. Chem. Soc. 
1939 , 61 , 2890 –2895 . 10.1021/ja01265a088 .
a Kadnikov D. V. ; Larock R. C. 
Synthesis of 2-Quinolones
via Palladium-Catalyzed Carbonylative Annulation of Internal Alkynes
byN-Substitutedo-Iodoanilines . J. Org. Chem. 
2004 , 69 , 6772 –6780 . 10.1021/jo049149+ .15387602  b Battistuzzi G. ; Bernini R. ; Cacchi S. ; De Salve I. ; Fabrizi G. 
4-Aryl-2-quinolones through a Pseudo-Domino Heck/Buchwald-Hartwig
Reaction in a Molten Tetrabutylammonium Acetate/ Tetrabutylammonium
Bromide Mixture . Adv. Synth. Catal. 
2007 , 349 , 297 –302 . 10.1002/adsc.200600342 . c Berrino R. ; Cacchi S. ; Fabrizi G. ; Goggiamani A. 
4-Aryl-2-quinolones
from 3,3-Diarylacrylamides through Intramolecular Copper-Catalyzed
C-H Functionalization/C-N Bond Formation . J.
Org. Chem. 
2012 , 77 , 2537 –2542 . 10.1021/jo202427m .22283237 
Lin J.-P. ; Long Y.-Q. 
Transition metal-free
one-pot synthesis of 2-substituted
3-carboxy-4-quinolone and chromone derivatives . Chem. Commun. 
2013 , 49 , 5313 –5315 . 10.1039/c3cc41690a .
Wang Y. ; Liang H. ; Chen C. ; Wang D. ; Peng J. 
One-Pot Synthesis
of Quinolin-4(1H)-one Derivatives by a Sequential
Michael Addition–Elimination/Palladium-Catalyzed Buchwald–Hartwig
Amination Reaction . Synthesis 
2015 , 47 , 1851 –1860 . 10.1055/s-0034-1380496 .
a Huang C. ; Guo J.-H. ; Fu H.-M. ; Yuan M.-L. ; Yang L.-J. 
Facile synthesis of 4-quinolone derivatives
via one-pot cascade reaction under transition-metal-free conditions . Tetrahedron Lett. 
2015 , 56 , 3777 –3781 . 10.1016/j.tetlet.2015.04.060 . b Chen X. ; Bai H. ; Huang C. 
Concise Synthesis of Quinolinone Derivatives . Chin. J. Org. Chem. 
2017 , 37 , 881 –888 . 10.6023/cjoc201611003 .
Zewge D. ; Chen C.-y. ; Deer C. ; Dormer P. G. ; Hughes D. L. 
A Mild
and Efficient Synthesis of 4-Quinolones and Quinolone Heterocycles . J. Org. Chem. 
2007 , 72 , 4276 –4279 . 10.1021/jo070181o .17458997 
CCDC
1580410 2a contain the supplementary crystallographic
data for this paper. This data can be obtained free of charge from
The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.

